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Background: Traditional evaluation techniques for spastic hypertonia, such as the Modified Ashworth 
Scale (MAS), are prone to subjectivity and have been shown to have poor inter- and intra-rater reliability. 
Automated objective electromechanical devices for upper-limb evaluation do exist, such as the 
commercially available NeuroFlexor device. These assess combined wrist and finger flexor tone by 
monitoring wrist joint torque during passive wrist extension. Wrist flexor tone evaluations made by 
manipulation of the wrist joint alone, however, could be affected by possible hypertonia of the finger 
flexors due to the moment arm that these muscles‟ tendons have at the wrist joint. As such, robotic wrist 
flexor evaluation devices that measure only the wrist joint torque cannot distinguish between wrist and 
finger flexor hypertonia. Hypothesis: A robotic device measuring involuntary resistance at the wrist and 
finger joints separately during wrist manipulation can be used to provide wrist flexor tone assessments 
that compensate for the influence of hypertonia of the finger flexor muscles, and therefore provide more 
accurate tone assessments of the wrist flexor muscles. Objectives: To design, construct and evaluate a 
patient-safe device for the independent measurement of wrist and finger joint torque during wrist 
extension, and to use the device to accurately evaluate wrist flexor tone, in isolation from possible effects 
of finger flexor tone. Methods:  Evaluations were made using the device in a clinical setting with 
volunteers (n=6) with varying levels of hypertonia in the hands and wrists. Volunteers‟ wrist flexor tone 
was also assessed by three clinicians using the MAS score. Results: The averages of therapist 
assessments were compared to the force applied at the wrist joint as measured by the device, as well as to 
an estimate of the wrist flexor tendon tension made using the device assessments with a biomechanical 
model. Both of the force evaluations made using the device (peak wrist force and estimated wrist flexor 
tendon tension) correlated identically with the MAS scores (ρ=0.81, p<0.05). Various factors could have 
influenced the correlations, however, such as the unreliability of the MAS as a gold standard.  
Conclusion: Results suggest that the estimate of the wrist flexor tendon tension offers no benefit over 
peak wrist force alone for wrist flexor tone assessments. This could indicate that the influence of finger 
flexor hypertonia at the wrist joint is small compared to that due to wrist flexor hypertonia, although 
further investigation is required to improve experimental robustness. The opportunity exists to make 
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Neurological disorders often result in motor dysfunction which causes substantial disability in 
patients. The healthy motor system relies upon reflexes to maintain innate tone in muscles as well as 
for rapid responses to potential threats. Upper motor neuron lesions, however, can result in a variety 
of observable signs and features of motor dysfunction collectively termed Upper Motor Neuron 
Syndrome (UMNS). These can be broadly categorized into negative or positive features which result 
in losses of function (e.g. paralysis) or excesses and hyperactivity respectively (e.g. spasticity). 
Negative features often result from the disruption of direct commands issued from the brain. The 
positive features are often a result of disruption of the brain‟s ability to modulate healthy reflex action. 
UMNS is commonly associated with disorders affecting the central nervous system. The most 
commonly observed cases occur with disorders such as cerebrovascular accident (i.e. stroke), multiple 
sclerosis, cerebral palsy, traumatic brain injuries and spinal cord injuries. 
While the features of UMNS are often easily observed, seeking consensus on formal definitions has 
proven less facile. For example, the term „spasticity‟, which refers to a velocity-dependent increase in 
tonic stretch reflexes, is often used incorrectly in the field as a catch-all term encompassing all 
observations of increased muscle tone. A more correct term would be „hypertonia‟, which doesn‟t 
imply velocity dependence. 
In clinical practice, the evaluation of muscle tone is often performed by making use of ordinal scales - 
most commonly the Modified Ashworth Scale (MAS). The convenience offered by such techniques is 
enough to outweigh the inherent flaws, specifically rater subjectivity and unreliability. The use of 
robotic devices for the evaluation (and also for treatment) of motor disorders is not a new trend, 
although it has largely been confined to the research environment. The results of such research have 
indicated clear benefits over traditional techniques.  
The research presented in this thesis sought to improve upon some of the work that has been done in 
the field of objective hypertonia evaluation. An electromechanical device for this purpose was sought, 




1.1. Physiology Background 
1.1.1. Neuroanatomy of the Healthy Motor System 
Within the Central Nervous System (CNS), the ultimate planner and controller of the body and its 
functions, motor control can be divided into hierarchical levels. Marieb and Hoehn (2006) name these 
as, in descending hierarchical order, the pre-command level (the most complex, comprised of the 
basal ganglia and cerebellum), the projection level (the upper motor neurons of the motor cortices and 
brainstem) and the segmental level (spinal cord circuits). The segmental level, being of interest here, 
will be discussed further. 
The segmental level is responsible for, among other things, the elements of the neuromuscular system 
which need not be under direct voluntary control. Stretch reflexes are an example: The intrafusal 
muscle spindles sense the stretch and transmit signals along the large type Ia fibres (the sensory 
endings of which are stimulated by rate and degree of stretch) and type II (stimulated by degree of 
stretch only). These afferent fibres enter the spinal cord as an input to spinal circuitry as well as to 
relay proprioceptive information to the brain. In the case of the aptly named monosynaptic stretch 
reflex, the spinal circuitry is as simple as a single synapse with an efferent α-motor neuron that exits 
the spinal cord to stimulate the same muscle in which the original stretch stimulus occurred. As such, 
when a muscle is sharply stretched it also experiences an involuntary contraction (see Figure 1.1).  
As the required response to stimulus grows in complexity, so too does the complexity of the spinal 
circuitry controlling it. The flexor or “withdrawal” reflex exhibits more complex movement as well as 
reciprocal inhibition whereby muscles which act antagonistically to the reflex are actively inhibited, 
requiring the presence of so called interneurons. More complex still are reflexes that require activation 
or inhibition of contralateral muscles to maintain balance and posture upset by the intended reflexive 
movement (see figure 1.2). Healthy stretch reflexes are under the influence of supraspinal modulation. 
That is to say, the brain can exert a level of control over the gain (the amplitude of the response) or 
threshold (the level stimulus required to elicit a response) of the reflexes‟ spinal circuitry. This is 
achieved via the pyramidal tracts (from the cortices) and parapyramidal tracts (from the brainstem – 
vestibular nucleus, superior colliculus and reticular formations) (Stevenson and Thompson, 2006).  
“By sending commands to the motor neurons, the brain essentially sets a muscle‟s 
length. The stretch reflex makes sure that the muscle stays at that length” (Marieb 
and Hoehn, 2006) 
As will be discussed in section 1.1.2., it is the interruption of this modulation that is thought to be the 




Figure 1.1 Illustration of the nervous pathways involved in the monosynaptic stretch 
reflex (Stevenson and Thompson, 2006) 
 
According to Stevenson and Thompson (2006), muscle tone refers to “the ongoing tension in a 
muscle, apparent as a resistance experienced to passive movement and stretch”, however the 
resistance itself can be attributed to two prime sources. These are chiefly the neural component due to 
the stretch reflex and the non-neural component due to the viscoelastic (biomechanical) properties of 
the connective tissue and muscles crossing the joint.  The term “muscle tone” can be somewhat 
confusing, since resistance is not only due to muscle contraction in an intuitive sense. As Barnes and 
Johnson (2001) state, it is worthwhile to note that while both factors (neural and non-neural) can 
contribute to pathologically increased muscle tone, normal muscle tone (i.e. passive resistance to 
manipulation) is comprised entirely from soft tissue biomechanics and there is no contribution from 
neurological components at normal passive movement velocities. In a pathological state, both neural 
and non-neural hypertonia (increased tone) can be exhibited (this is discussed in Section 1.1.2). 
Indeed, it is important to distinguish between neural and non-neural hypertonia because the treatments 
paradigms for these are affected – such as stretching and/or splinting, pharmacology or even surgery. 
Methods suggested for making such a distinction include careful examination of the affected body 
segments with fast and slow passive joint manipulation, as well as less subjective methods such as 
electromyography (EMG) analysis and the use of techniques such as local anaesthetic or ischemic 
nerve blocks to temporarily negate the effects of any neural hypertonia and observe if resistance is 




Figure 1.2 The flexor (or “withdrawal”) reflex, illustrating how more complex 
reflexes can cause muscle activity in contralateral segments to the original 
stimulus.  (Marieb and Hoehn, 2006) 
 
by Albani et al. (2010) have used EMG to quantify an increase in muscle tone, and as such would 
only detect the neural components thereof. Lindberg et al. (2011) have used torque measurement and 
biomechanical models to distinguish between neural and non-neural hypertonia.  
 
1.1.2. Upper Motor Neuron Syndrome, Spasticity and Hypertonia 
Upper Motor Neuron Syndrome (UMNS) is the collective term for a set of observable neurological 
features, any of which can develop after an upper motor neuron lesion.  The common features of 
UMNS are shown Table 1.1. As can be seen, such features of UMNS can be divided into negative 
(losses) and positive (excesses).  
It is thought that the positive features of UMNS are due, at least in part, to the interruption of the 
genesis or transmission of modulating signals from the central nervous system which interact with the 




Table 1.1 Features of Upper Motor Neuron Syndrome (Barnes and Johnson, 2001) 
Positive Features Negative Features 
 Increased tendon reflexes   Muscle weakness 
 Clonus  Loss of dexterity 
 Positive Babinski sign  Reduced postural response 
 Spasticity 
 
 Extensor spasms 
 
 Flexor spasms   
 Mass reflex 
 
 Dyssynergistic patterns of co-
contraction during movement  
 
 Associated reactions and other 
dyssynergistic and stereotypical 
spastic dystonias  
 
Among the medical community, consensus for a precise and all-encompassing definition for 
“spasticity” has proven elusive - with good reason. The most widely quoted definition among 
scholarly publications was put forward by Lance (1980): 
“[Spasticity is] a motor disorder, characterized by a velocity-dependent increase in 
tonic stretch reflexes (muscle tone) with exaggerated tendon jerks, resulting from 
hyper-excitability of the stretch reflex as one component of the upper motor neurone 
syndrome.” 
While this definition seems simple and clear, the phenomenon is still poorly understood in clinical 
practice. Most physicians and clinicians will agree that they can identify spasticity when they 
encounter it in their patients, however their observations do not strictly conform to how they perceive 
Lance‟s definition. The use of the term and the definition thereof has been the subject of criticism 
(e.g. Malhotra et al., 2009, showed that a large proportion of studies do not confirm to a single 
definition or even explicitly state a definition). Barnes and Johnson (2001) explain further:  
“It may be difficult for a clinician to correlate this definition with a typical patient 
pictured in his or her mind…. The clinician tends to picture the whole UMN 
syndrome and regard all the „positive‟ features of the syndrome as „spasticity‟.”  
6 
 
The research by Ibrahim et al. (1993) show that spastic response is not as simple as Lance‟s definition 
implies, with early and late responses to passive stretch (observable both with torque and EMG 
measurement).  
Often, clinicians will apply the term „spasticity‟ to any increase in muscle tone (although „hypertonia‟ 
would be a better term). True spasticity is velocity-dependent and as such often exhibits a specific 
presentation, such as the clasp knife phenomenon (upon passive stretch, a muscle will briefly contract 
or “catch” followed by a release). In the case of increased tone over the whole range of motion 
(without the initial catch), a more correct name would be neural hypertonia, but soft tissue changes 
should be investigated since tone can have non-neural origins. 
Over the years since Lance‟s initial description, new definitions for spasticity have been proposed 
such as the following by the EU-SPASM group in 2005 (Pandyan et al., 2005): 
“Spasticity – disordered sensorimotor control, resulting from an upper motor neuron 
lesion, presenting as intermittent or sustained involuntary contraction.” 
This definition is broader and consequently it becomes less useful in the evaluation and treatment of 
spasticity. Despite this, it is the definition that will be adopted for the remainder of this thesis due to 
having the advantage of being an „umbrella‟ term. This was motivated by the fact that, in interviews, 
clinicians appear to use the terms “spasticity” and “hypertonia” interchangeably. 
UMNS and Spasticity are associated with a number of diseases and causes. Some affect the spinal 
cord while others affect the brain directly. For a disease to result in exhibition of some or all of the 
features of UMNS, it must inhibit the transmission of communication between the brain and the spinal 
circuitry and stretch reflexes (or inhibit the genesis of such communications). The most commonly 
associated causes of spasticity are listed below, but this list is by no means exhaustive: 
 Cerebrovascular accident (i.e. a stroke) is the most common cause (see the discussion of 
prevalence in Section 1.1.3). 
 Diseases such as Amyotrophic Lateral Sclerosis, Multiple Sclerosis,  brain or spinal cord 
neoplasms, certain forms of cerebral palsy such as spastic diplegia (also known as Little‟s 
disease), etc. 




1.1.3. Prevalence of UMNS and Spasticity 
Little reliable data exists on the incidence of spasticity, and even less on UMNS in general. For 
instance, in a study by Sommerfeld et al. (2004), it was concluded that 19% of stroke patients (n=95) 
experienced spasticity in the first 3 months following a stroke, and 20% after 18 months. Watkins et 
al. (2002) concluded that 29% of their cohort (n=106) showed increased muscle tone after 12 months. 
Indeed, the latter study also showed up to 38% of their cohort exhibited spasticity if a different kind of 
assessment scale was used (The Tone Assessment scale, as opposed to the MAS, discussed in Section 
1.1.5). A study of multiple sclerosis by Barnes et al. (2003) reports that 47% of participants developed 
spasticity (n=65). This is somewhat inconsistent with the results presented by Rizzo et al., (2004) 
from a much wider study (n=513) which stated that up to 70% of multiple sclerosis patients will 
experience “some degree of spasticity”.  
Symptoms may be experienced in lesser or greater degrees by different people – indeed even the same 
person at different times - the difference in study conclusions may be attributed to, among other 
things, what degree the authors deem symptoms to be clinically significant or the evaluation methods 
currently employed. Another source of inconsistency could arise in the working definition of 
spasticity being used in each study. While all of the three studies cited here assessed multiple 
parameters in their participants (motor performance, dexterity, etc.), “spasticity” was assessed in two 
of the three by means of the MAS score (see Section 1.1.5). The trial by Rizzo et al. (2004) 
investigated participant-reported spasticity using their own definition and ordinal scale. This ad hoc 
definition was „unusual tightening of muscles that feels like leg stiffness, jumping of legs, a repetitive 
bouncing of the foot, muscle cramping in legs or arms, legs going out tight and straight or drawing 
up‟ and the ordinal scale, like the MAS, ranged from 0 to 5. It was worded to test the frequency with 
which „spasticity‟ interfered with daily activities. None of the studies used any non-subjective 
measures to test for spasticity or UMNS, and none truly measured spasticity in terms of Lance‟s 
definition (see Section 1.1.2). Nonetheless, despite the insufficiency and inconsistency of the 
literature, what it does illustrate is that spasticity is a common effect of such neurological disorders as 
stroke and multiple sclerosis.  
In the South African context, when one compares the results of recent censuses conducted in 1996 
(Lehohla, 1998) and 2001 (Lehohla, 2003), the population group aged 60 or older increased from 2.8 
million to 3.3 million over the five year period. This increase of 16.1% is disproportionate to the total 
population increase of only 10.4% over the same period. This disproportionate increase is again 
observed (and drastically increased) in the 2011 census (Lehohla, 2012) – the population aged 60 or 
older grew by 26.6% (to 4.2 million) from 2001, while the total population only grew 15.5%. This 
indicates that the population is aging. The increase in the proportion of elderly will affect the 
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occurrence of strokes (since age is a significant risk factor for stroke) and as thus the prevalence of 
resultant UMNS.  
A similar contribution to patient numbers is imposed, ironically, by advances in the stroke treatment: 
While a trend towards more effective emergency stroke treatment methods is yielding an increase in 
the number of stroke survivors, it is also increasing the number of patients requiring rehabilitation. 
The problem of increasing patient numbers is compounded by the limited usefulness of effective 
evaluation techniques, and financial constraints (which preclude most of the expensive technological 
evaluation or rehabilitation aids currently available on the market). A result of this is that there is a 
trend towards disability compensation in rehabilitation due to facility constraints regarding patient 
volumes. It comes at the expense of impairment reduction which is clearly the better solution. That is 
to say, instead of rehabilitating patients such that they can perform tasks as they used to (impairment 
reduction), care facilities are teaching patients to “work around” their disabilities (disability 
compensation).   
 
1.1.4. Clinical Observations in UMNS 
Precise clinical consequences and observations of UMNS are difficult to predict, as the possible 
manifestations from any neurological disorder are often numerous. The specific manifestations will 
depend on the neurological structures involved. In terms of positive features, severity in a patient can 
sometimes fluctuate and can often be affected by many factors such as cutaneous stimulation (i.e. 
from clothing), the patient‟s level of fatigue, and even their emotional state or alertness. Often, but not 
always, spasms are stronger either during passive flexion of a joint rather than extension, known as 
flexion dominance, or vice versa, known as extensor dominance. Severe hypertonia could manifest as 
rigidity of the joint in both directions. Flexion dominance, more commonly observed in the upper 
limbs, often leads to the commonly observed posture in those presenting with abnormal tone in the 
upper limb adopts: adducted and internally rotated shoulders, flexion of the wrist, elbow and fingers 
((Thibaut et al., 2013). This flexion dominance, which is not always observed, is can be observed in 
the results of a study done by Sherwood et al. (2000), in which the EMG during passive movement of 
spastic subjects‟ hip joints were recorded and analysed.  
UMNS, especially severe cases, demands specific considerations from care givers: 
 Impairment of movement in the fingers and wrist can affect the ability to perform activities 






Figure 1.3 Commonly adopted posture in spastic patients – adduction and internal 
rotation of the shoulder, and flexion of the elbow, wrist, and fingers 
(Thibaut et al., 2013) 
 
 Indeed, depression and frustration brought on by dependence on caregivers or failure to 
perform simple tasks can warrant special psychological care considerations.  
 If the lower limbs are affected, then patient mobility becomes impaired. In mild cases, the 
subject may require a crutch, cane or walker. More severe cases will confine a patient to bed 
or a wheelchair. Subjects are frequently elderly (age is the primary risk factor for stoke, a 
common cause of spasticity), and a fall due to impaired mobility can result in significant 
trauma.  
 In these severe cases, where patients require wheelchairs, spasticity in the lower limbs can 
result in pressure sores arising from abnormal seating postures.  
 Hygiene concerns are also paramount. If a patient‟s spasticity causes a permanently rigid and 
clenched fist, then cleaning inside the palm or trimming of the patients fingernails may prove 
difficult.  
 If left untreated, or if improperly treated, the rigidly contracted muscles will undergo 
contractures – permanent and often painful conversion of muscle to connective tissue. Once 
developed, contractures cannot be “stretched out”, but can only be alleviated surgically, so 
their prevention is critical. 
 Personal communications with care givers have confirmed that the time consuming physical 




1.1.5. Assessment and Treatment 
There exist varying techniques to evaluate hypertonia. Both qualitative and quantitative techniques 
exist, with varying levels of reliability and practicality. Quantitative assessment relies on the use of 
specialized instrumentation. This is discussed further in Section 1.2. Qualitative systems, largely in 
the form of ordinal scales, have been more accepted in clinical practice, since they are fast, simple and 
do not require expensive or specialized equipment. Their disadvantage is that they are less reliable - 
the subjectivity and lack of resolution of these scales limits their practical use (reliability will be 
discussed shortly). A widely accepted measure of increased muscle tone is the Modified Ashworth 
Scale - an ordinal scale in which the tester assigns the subject a score from zero to four, where zero 
represents a normal level of functionality, observed in a healthy subject. It is so named because it is a 
revision of the similar Ashworth scale, modified to improve discrimination between mild and 
moderate increases in tone – see the addition of the „1+‟ option in Table 1.2. Other ordinal scales 
include the Fugl-Meyer score which assesses levels of functional impairment including balance, joint 
range of motion, and a number of other measures (Duncan et al., 1983). Alternatives such as the 
Tardieu Scale are also sometimes used to measure spasticity, but require some training to perform. 
The Tardieu Scale involves manipulating a joint at three specific velocities and noting the joint angle 
at which an involuntary resistance is felt. While there are numerous available methods for 
measurement, the MAS score is by far the most widely practiced. 
Table 1.2 The Modified Ashworth Scale for evaluation of muscle tone 
Score Description 
0  No increase in muscle tone. 
1 Slight increase in tone with a catch and release or minimal resistance at end of range. 
1+ As for 1 but with minimal resistance through range following catch. 
2 More marked increase tone through range of motion. 
3 Considerable increase in tone, passive movement difficult. 
4 Affected part rigid in flexion or extension. 
 
The MAS assessment was first applied by Bohannon and Smith (1987). It was used to assess elbow 
flexor spasticity. The procedure was as follows: 
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1. The patient is to be in a supine position on a padded mat or table  
2. The arm was stabilized proximal to the elbow, and the forearm was grasped distally (just 
proximal to the wrist). The forearm was in neutral supination. 
3. The patient‟s elbow was extended from a position of maximal flexion to maximal extension 
over a period of 1 second 
4. Five to eight sequential extensions were performed 
5. The patient was graded using the MAS score (Table 1.2) 
Opinion on the reliability of the MAS score especially remains equivocal. While some studies claim 
that the method is acceptable (Bohannon and Smith, 1987; Brashear et al., 2002) others suggest that 
one or more aspects of the test are not reliable enough (Blackburn et al., 2002; Ansari et al., 2006; 
Alibiglou et al., 2008; Mutlu et al., 2008; Fleuren et al., 2009) or that further work was needed to 
determine the scope and limitations of the technique (Pandyan et al., 1999).  Common criticisms are 
that the scales have poor intra- and inter-rater reliability due to the lack of objective quantification and 
thus a reliance on the physiotherapist‟s interpretation of the wording. For example, the point at which 
a “slight increase” in muscle tone becomes a “more marked increase” is subjective. Furthermore, the 
scale cannot distinguish between neural and non-neural hypertonia (see Section 1.1.1). Despite these 
shortcomings, the MAS score is commonly used as a measure of hypertonia in research, and is often 
treated as an acceptable proxy for hypertonia severity. It is, however, often used in research in 
conjunction with other related outcome measures, or quantifications of muscle activity (e.g. 
electromyography).  
Examples of such evaluation measures include the passive range of motion (PROM), and 
measurement of torque or the resistance to passive motion (Bovendeerdt et al., 2008). These are 
usually used in conjunction with other measures. Also noteworthy is that a relationship between the 
passive ROM and the severity of hypertonia has been shown (Pizzi et al., 2005). See Figure 1.4. 
Treatment regimens may consist of various elements, depending on the severity of symptoms. Almost 
all neuromuscular rehabilitation programs will include a stretching routine (Bovendeerdt et al., 2008; 
Smedes et al., 2014), and more severe cases will include prescription medication indicated for 
spasticity such as Baclofen, or botulinum toxin type A (Botox). Therapy is usually conducted by 
trained clinicians, as is the evaluation of the level of severity of hypertonia. Since there is no one 
“cause” for UMNS, and because the exact pathophysiology and mechanisms behind components like 
spasticity are unknown, there are many varying viewpoints regarding the proper courses of action to 
take. Berta and Karel Bobath pioneered the concept of “neuro-developmental treatment” (also known 
as NDT or the „Bobath‟ concept), which is one of the major approaches to CNS pathology. It is non-
standardized, broad and evolving concept, largely involving employment of techniques to guide 
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patients towards completion of tasks. It has been the subject of scientific study (Paci, 2003; Kollen et 
al., 2009). A good review of rehabilitation techniques for the positive signs of UMNS was published 
by Logan (2011). In this review, it is remarked that therapists need multiple modalities, and that 
evidence shows that no one modality is sufficient for improvement. They conclude that therapies need 
to be “high intensity, repetitive, and task specific, and they need to provide feedback on performance 
to produce functional changes”. 
 
Figure 1.4 Relationship between severity of spasticity (MAS score), and passive 
range of motion (PROM) at the wrist. Values are mean ±1 standard error 
of the mean (SEM). (Pizzi et al., 2005) 
 
1.2. Robot-aided Neuro-rehabilitation and Objective Evaluation of 
Hypertonia  
The challenges for therapists are mounting, and advancements in robot-aided therapy are intended to 
alleviate this burden. Electromechanical devices have been shown to assisting in neuro-rehabilitation, 
although this is still a relatively new trend. Similarly, devices have been used in clinical environments 
for the purpose of objective evaluation of the various features of UMNS, as well as to aide therapy 
while having evaluation as a secondary feature: technological therapy aides often have their own 
outcome measures, such as quantification of the ability of participants to perform tasks.  
Technological devices are slowly finding their way into clinical practice. Simple torque-measurement 
devices have been applied to the purpose of hypertonia evaluation, and in some cases these devices 
have been developed into commercially available products (see Section 1.2.2). Similarly, robotically 
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aided rehabilitation has largely been a practice confined to the research environment, although 
recently research devices are being commercialized (see Section 1.2.1).  
Commonly cited (although somewhat dated) reviews of robotically aided rehabilitation devices were 
presented by Riener et al. (2005) and Prange et al. (2006). Furthermore, in a research setting, the 
effectiveness of robotic rehabilitation devices is usually assessed against one or more traditional 
evaluation methods. A recent review of the outcome measures used in assessment of robot-assisted 
exercise trials (RAET) was presented by Sivan et al. (2011).  
Volpe et al. (2001) raised the question of robot aided therapy as a realistic option - and indeed, the 
same concerns could be raised about technological solutions for objective evaluation as opposed to 
traditional, subjective assessments. They conclude their review with the following statement: 
“A final determination regarding whether the use of robotic devices in stroke 
rehabilitation is realistic needs to be postponed, because more work is required. 
However, arguments have been advanced that the proper question might be whether 
neglecting to arm the therapist with new tools, among them robotic devices, can 
continue to be a realistic option.” 
 
1.2.1. Examples of Electromechanical Devices for Rehabilitation 
The following section gives examples of robotic rehabilitation aides. These largely appear to be 
designed to assist with paresis (i.e. muscle weakness associated with negative features of UMNS) as 
opposed to hypertonia. Furthermore, the majority of attention has been devoted to rehabilitation aides 
for the shoulder and elbow (proximal arm rehabilitation), rather than the hand/wrist. Despite not 
having direct clinical relevance to this research, some examples of these are discussed here, because 
their design provided insight into the design challenges presented by upper limb exoskeleton devices, 
and also because some examples have evaluation features built in. It should be noted that this 
discussion only includes a selection of prominent devices in the field, and is not exhaustive.  
Some devices act as assistive movement aides, providing the subject with assistance in their 
rehabilitation exercises when needed. The most prominent examples that come up in the field are the 
MIT-Manus robotic rehabilitation aide (see Figure 1.5). This class of devices was patented in 1995 
(Hogan et al., 1995) and has been extensively studied, developed and reviewed since then (Krebs et 
al., 1998, 2004, 2007; Volpe et al., 1999). Recently, the MIT-Manus device has been commercialized 
by Interactive Motion Technologies, Inc. as part of the InMotion range of rehabilitative robots.  
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The MIT-Manus and InMotion devices attempt to assist in rehabilitation by encouraging neural 
plasticity after central nervous system impairment. The subject is prompted to perform certain goal-
directed movements, and is mechanically assisted by the device if he or she lacks the ability to 
complete it. If the subject has an extremely weak arm then the robot will provide a larger assistance, 
but if the patient has more strength, then little or no assistance will be supplied. This principle is 
sometimes referred to as the „assist when needed‟ approach. Similarly, the device will help to correct 
involuntary movement such as spasms. In mechanical terms, to allow this the robot must be back-
drivable - that is to say that it must have low intrinsic endpoint mechanical impedance. This advantage 
of reinforcing neural links to stimulate plasticity is not offered by passive stretching techniques. In 
other words, if the limb is only passively stretched then the brain will not “re-learn” how to control 
the affected limb. 
The original versions of the MIT-Manus did not originally extend rehabilitation to the hand or wrist 
for grasping tasks, and movements were almost entirely restricted to the horizontal plane (a small 
amount of passive vertical motion was allowed by means of springs). Since its original incarnations, 
extensions to the MIT-Manus have been developed to allow movement in the vertical direction (Krebs 
et al., 2004) and also to allow hand and wrist training (Krebs et al., 2007).  
 
Figure 1.5 A subject demonstrating the use of the MIT-Manus for shoulder and 
elbow rehabilitation in the horizontal plane with two degrees of freedom 




It is generally accepted that while passive stretching should be a part of the therapy regimen, there 
should also be a large component of task-oriented “learning”. The MIT-Manus achieves interactive 
task-orientated therapy with a display prompting the user to perform tasks. The device includes data 
logging elements which record patient performance (force, velocity, position, EMG, etc.) and can 
provide feedback in the form of various metrics (see Figure 1.6).  
 
Figure 1.6 Position and speed plots of a patient using the MIT-Manus device to draw 
clockwise circles starting at the 9 o‟clock position, showing improving 
ability to smoothly and accurately perform the task through various stages 
of rehabilitation. The hand was within view, but no explicit feedback was 
provided. Note that no robotic assistance was provided for motion in this 
exercise, since the intention was to test patient performance. (Krebs et al., 
1998). See Figure 1.5. 
 
(Takahashi et al., 2005) developed the Hand Wrist Rehabilitation Assistive Device or HWARD as a 
sensorimotor rehabilitation aide (see Figure 1.7). The device has three degrees of freedom 
(flexion/extension of wrist, fingers as a whole and thumb), and is intended for the rehabilitation of 
hand weakness. It is pneumatically actuated and back-drivable, and employs separate monitors and 
software for interaction with the participant and the examiner (each has their own monitor). The 
device design minimally obstructs the palmar surfaces of the hand, so that grasping tasks can be 
exercised. Similarly to the MIT Manus, therapy with the device is not passive, but rather requires 
movement to be initiated by the participant, and the device would assist in completion of the task if 
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necessary. While the 2005 paper only describes the design of the device, in more recent work 
researchers assessed the effectiveness of the device as a rehabilitation aide (Takahashi et al., 2008). 
Over the course of 3 weeks, patient‟s motor abilities using a number of tests were monitored 
(including the MAS score). EMG in three muscles, and functional magnetic resonance imaging 
(fMRI) studies were also conducted before and after treatment to assess the benefits of therapy with 
the device. The behavioural and motor ability scores mostly showed improvements. The fMRI 
findings showed significant and interesting cortical reorganization (see Figure 1.8), but the EMG 
study failed to show significant muscle activation improvement post-therapy. This indicated a cortical 
reorganization, but not task performance improvement.  Behavioural gains were observed, however, 
in other outcome measures (such as the Fugl-Meyer score). 
 
Figure 1.7 Subject demonstrating the use of the HWARD hand rehabilitation robot. 
Note the unobstructed palmar surface of the hand, allowing grasping of 
objects (Takahashi et al., 2005) 
 
The REHAROB system (specifically designed for treatment of spastic hemiparesis) attempted the use 
of standard, unmodified industrial robots for rehabilitation (see Figure 1.9). The results of clinical 
trials were presented by Toth et al. (2005), showing that the device is safe and performs as intended. 
With the REHAROB system, exercises can be three-dimensional, complex, anti-spastic passive 
movements, however the device is completely passive and movements are completely prescribed. The 
operation of the device involves strapping the patient into the device, following which the therapist 
“teaches” the device the motions that are required by manipulating the patients arm and the device 
together. At this point, the therapy program can be edited (such as decreasing the velocity of 
movements), and then “played back” – the device recreates the learned movements to the desired 




Figure 1.8 fMRI activation volumes before and after treatment with the HWARD 
hand device, illustrating clear increases of activation volume in the 
practised task (grasping) but not for the unpractised task (supination). 
(Takahashi et al., 2005) 
 
Devices such as the Mirror Image Movement Enabler or MIME (Burgar et al., 2000) and the Bi-
Manu-Trak (Hesse et al., 2005) (see Figure 1.10 and Figure 1.11 respectively) use a technique to 
enhance rehabilitation whereby the affected hand‟s movement is guided by the movement of the 
unaffected hand. The patient is asked to perform the same action in both hands, such as pronation of 
both forearms, but will have impaired control over one hand due to their pathology. The machine will 
exert appropriate forces onto the more affected limb to mirror the movements of the less affected 
limb. In addition, the MIME machine has a setting which allows for passive (predefined) movement, 
which is not initiated by the patient. It was deemed that while task-oriented movement is effective at 
encouraging cortical plasticity, passive movement was also beneficial in treatment. 
The devices discussed in this section are designed to be used as rehabilitation aides, but often will 
incorporate some form of outcome measure. For example, in-depth information was recorded by the 
MIT-Manus device, such as joint torques and velocities as well as EMG. It should be noted, however, 
that while devices such as the ones discussed in this section often include internal evaluation systems, 
these remain secondary to rehabilitation features of the device. As will be discussed in Section 1.2.2, 





Figure 1.9 A subject demonstrating the REHAROB robot, an adapted industrial robot 
for passive movement of the upper extremity (Toth et al., 2005) 
 
 
Figure 1.10 Unilateral (a), and bilateral (b) movements with the MIME device (Burgar 




    
Figure 1.11 Bi-Manu-Trak device bilateral forearm pronation/supination (a), and wrist 
flexion/extension (b)  (Hesse et al., 2005) 
 
1.2.2. Devices for Objective Evaluation of Hypertonia  
In this section the use of electromechanical devices to quantify muscle performance (including 
increases in muscle tone), will be discussed.  
As was discussed in Section 1.1.5, the most commonly used evaluation techniques for hypertonia are 
ordinal scales, such as the MAS score. The clinical popularity of such methods has been largely due to 
the convenience benefit. The reliability and resolution of these scales, however, have driven research 
into technological alternatives. EMG has also been used to provide an indication of muscle activity 
for research involving muscle tone (e.g. Levin and Feldman, 1994; Jobin and Levin, 2000). 
The complexity of such devices varies from simple hand held instruments to large non-portable 
systems. Smaller devices offer convenience, but are limited in their functionality to that for which 
they were designed (for example, only being useful for assessment of one joint). Larger systems, such 
as the Biodex (“Biodex Dynamometers,” 2014), allow measurement of many parameters with many 
settings, and have been used to analyse muscle tone. For example, computational techniques have 
been used with similar such devices and to separate the effects of muscle, passive stretch and reflexive 
action (Mirbagheri et al., 1998, 2000; Alibiglou et al., 2008) Furthermore, such systems allow features 
as computer-numerically controlled isokinetic evaluation. However, while intuition dictates that 
isokinetic systems would provide better results than simple hand-held systems due to the velocity-
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dependent nature of spasticity, this may not necessarily be the case, as is suggested by the results 
when different systems are compared (Boiteau et al., 1995).  
 
The Myoton device (see Figure 1.XX) is a small, hand-held device for quantifying muscle tone. 
Reliability of the device has been demonstrated, but it has yet to be used outside of a research 
environment. The device uses the myotonometric measure (Bizzini and Mannion, 2003) for estimating 
muscle tone: the device is pressed gently against the skin above the belly of the tested muscle and 
applies a short mechanical impulse. This causes a brief deformation in that muscle, followed by 
damped oscillations which are recorded by an accelerometer in the device. Muscle tone estimates are 
inferred based on the properties of the recorded oscillations.  
While electromechanical devices are common in the research environment, some devices are finding 
their way to commercial availability. A prominent example is the NeuroFlexor device (Lindberg et al., 
2011).  
The NeuroFlexor device, visible in Figure 1.12, is specifically designed to measure the resistive force 
during wrist extension. The designers presented a validation of a biomechanical model for use with 
the device that can help to isolate the neural component of this resistive force (Lindberg et al., 2011). 




Figure 1.12 Photograph of the NeuroFlexor device, a commercially available device 
for the evaluation of spasticity of the finger and wrist joint (“NeuroFlexor 
Online Brochure,” 2012). See Figure 1.13. 
 
According to their biomechanical model, the total resistive force can be subdivided into the passive 
and active components. The passive component can be further subdivided into the passive elastic 
force, viscous force and inertial force. The model is as follows: 
  ( )           ( )         ( ) 
(Equation 1.1) 
Where θ is the joint angle of interest, Fm is the total resistive force, FPassive is the passive component 
and FActive is the active (i.e. neural) component of this force. FPassive is comprised of elastic, viscous, 
and inertial components.  
 
   
 
Figure 1.13 Illustration of raw force data collected with the NeuroFlexor device for the 
slow (left) and fast (right) repetitions, indicating where the forces at the 
three points of interest (P1, P2 and P3) were noted (Lindberg et al., 2011). 
See figure F1.12. 
 
The values of the passive components of the total resistive force are estimated based on points of 
interest in the force data recorded during passive wrist extension across the range of motion at various 
velocities (see Figure 1.13). The neural component of the force recorded at the end of the range of 
motion is what remains when these passive components have been subtracted. 
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This neural component corresponds to the late stretch-evoked responses as observed by Ibrahim et al., 
(1993), and not the initial spinal stretch reflex (which has a latency of 40ms). 
The validation of this biomechanical model included the assessments of chronic stroke patients 
(n=31), while simultaneous EMG in addition to traditional assessments obtained with the MAS score 
and other performance measures.  
The primary method of validation of the model was to repeat the test with an ischemic nerve block in 
the affected limbs of some participants (n=7) to negate the effect of the neural component. Other 
analyses included correlating EMG power with the measured neural component, confirmation of 
velocity dependence of the neural component, and correlation between resistive forces and the MAS 
score.  
The results indicate that the model can be used to accurately separate the active and passive 
components of the resistive force. The authors reported that both the resistive forces and the neural 
components “correlated strongly” with the MAS score (r>0.6, P<0.001). In a thesis (an evaluation of 
the performance of the NeuroFlexor system), presented by Gäverth (2013) on the same work, it is 
reported that there is a stronger correlation between the MAS score and the total force than with the 
neural component alone. This finding suggests that the MAS score is a more accurate measure of 
passive resistance, rather than true spasticity.  
 
1.2.3. Opportunity for Further Development 
In short, the literature revealed that there is currently a trend towards robotics in rehabilitation (both 
for treatment and evaluation), and that there is a definite advantage to be offered by such methods. 
The art is, however, in its infancy. Many challenges exist, but these challenges are not 
insurmountable. While there are multiple devices that may assist in motor-rehabilitation and 
assessment of various features of UMNS, attention is seemingly diverted from hand/wrist therapy. 
Reaching tasks are important for day-to-day activities, but fine motor control is also important. As 
such, neither aspect of therapy should be neglected. They should be developed in parallel. 
While some devices exist, even commercially, for the evaluation of hypertonia in the hand and wrist, 
there is still opportunity for development. The NeuroFlexor device, as discussed in Section 1.2.2, 
measures the hypertonia in the fingers and wrist flexors, and even goes so far as to use a 
biomechanical model to distinguish between the neural and non-neural components of the increased 
tone. The device cannot, however, determine the relative contributions from each. This is because the 
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finger flexor muscles have a moment arm at the wrist joint (see Figure 1.12) and as a result, extension 
of the wrist joint acts to extend the finger flexor muscles as well. Hypertonia in the finger flexor 
muscles would result in a torque about the wrist joint which, using the NeuroFlexor in its current 
incarnation, would be indistinguishable from torque due to wrist flexor hypertonia. These two 
components (finger and wrist flexor hypertonia) are reported as a combined value. 
The opportunity exists to investigate the potential benefit of measuring the finger and wrist joint 
torques, either separately during finger and wrist manipulation respectively or possibly 
simultaneously during only wrist extension by measuring the force applied by the finger and wrist 
separately. Using the results from these separate analyses, and using a biomechanical model, it would 
be possible to develop a robotic device for the evaluation of wrist flexor hypertonia that compensates 
for the effects of finger flexor hypertonia thereby providing more accurate assessments. 
Following an investigation into the effects of isolating the finger and wrist flexor contribution to wrist 
joint torque has been established, future analyses on repeating the protocol of using the NeuroFlexor‟s 
approach (for isolation of the neural component of torque) can be considered.  
 1.3. Objectives 
The work presented in this thesis had two main objectives: 
 Objective 1 
To design and construct a patient-safe device for the manipulation and torque measurement of the 
wrist and finger joints, which can be used with a simple biomechanical model for wrist flexor muscle 
tone evaluation. 
Objective 2: 
To assess the evaluations obtained from the device in Objective 1 in a clinical setting, by comparing 
the device evaluation results to those from commonly used assessment methods: 
Compare the device evaluation using wrist-only force data to the average of three assessments from 
three clinicians: 
1-  Compare the torque measured at the wrist joint to evaluations using the Modified Ashworth 
Scale 
2- Compare the device evaluations using a biomechanical model which considers wrist and 
finger torques to evaluations using the Modified Ashworth Scale  
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A robotic exoskeleton for the manipulation of the hand and wrist joints was specifically designed and 
built to achieve the objectives of this research project (see Section 1.3). This device differs from the 
NeuroFlexor (see Section 1.2.2), in that it specifically measures the torque contributions from finger 
and wrist flexors separately, as opposed to only wrist torque. The design also features vertical joint 
axes to mitigate the possible effects of gravity on the outcomes (compare Figure 1.12 with Figure 
2.3). 
In this thesis, the mechanical components are referred to as “the device” for simplicity. All 
components as a whole – including the device, control electronics, cables and all other components - 
are referred to as “the system”. The device and its components are a subset of the system (see Figure 
2.2). This chapter provides an overview of system specifications, and more information about the 
design and manufacturing of the system is presented in Appendix A and Appendix B. 
The system used in this project was developed following consultations with neurologist Professor 
Alan Bryer and physiotherapist Carolyn Davids of the Department of Neurology and Physiotherapy at 
Groote Schuur Hospital, Cape Town, South Africa. These discussions yielded the initial clinical 
requirements for the system and, from these the starting point for the design was derived.  
 
2.1. Device Design Specifications 
The system functioned to emulate and automate the standard procedure for performing a MAS 
assessment. The device functioned as follows: 
 The system was designed for use with participants with mildly to moderately increased 
muscle tone of the wrist and finger joints (i.e. a MAS score of below 3). Participants with 
severe spasticity were excluded from testing. It was estimated that the resistance applied to 
each force transducer (wrist and finger joint) due to increased tone would be below 30 N.  
 The participant was secured into the device and asked to relax. Only involuntary resistance 
was of interest. 
 The system firmly but gently moved the participant‟s metacarpophalangeal joint (MCP or 
„knuckle‟ joint) and the wrist joint between the flexed and extended positions: 
o The finger joint was manipulated over a 90° range (from straight to 90° flexion).  
o The wrist joint was allowed a range of 105° (from 70° in flexion to 35° in extension).  
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These wrist ranges was selected based on the expected comfortable range of motion of 
participants with mildly to moderately increased tone (see Figure 1.4). 
 During the movement, force transducers measured the resistance to the passive motion (see 
Section 2.4).  
 A four channel EMG signal acquisition system was also included (see Section 2.3).  
The EMG signal acquisition system was used during the preliminary safety tests (see Section 3.1). 
These tests helped to confirm safety features which satisfy a part of Objective 1 (Section 1.3), namely 
that the device must be “patient safe”. Note that EMG did not directly verify safety of the device, but 
was merely used as an input for control of device movement during the preliminary safety tests. 
Safety was verified by observation that the device - especially safety features such as the safety 
buttons - operate as intended without malfunction. Safety features will be discussed in Section 2.2.3. 
Certain design philosophies were adopted as guiding principles during planning and development of 
the system. These were in addition to the basic engineering and clinical requirements and constraints 
of the system, such as safety and functionality. These important philosophies were as follows: 
 The system should, if possible, not be intimidating to the participant. For examples the use of 
plastic components where possible, instead of metal, so that the device appears less 
“industrial”.  
 The system should be easy to operate and require minimal training for the clinical staff. 
 The system should be easy to manufacture. Where possible, design should minimize 
specialized components. 
 
2.1.1. Coordinate system 
A rotational coordinate convention was adopted to specify device joint position, to indicate various 
levels of anatomical joint flexion and extension, and to indicate directions of applied forces or 
torques. Joint positions are measured from straight (i.e. aligned with the forearm), with positive angles 
indicating flexion (see Figure 2.1). For example, if the fingers were stated to be at +45 degrees, it 
meant that they were flexed at 45 degrees from straight. If the wrist is stated to be as -10 degrees, it 




2.2 Device Construction 
2.2.1. Overview of System Components 
For images of the system, see Figures 2.2 to 2.4. The device was invertible, meaning that it could be 
used to interface with either the left or the right hand of the participant. The system was designed to 
comfortably but firmly manipulate the wrist or finger joints in flexion or extension. The device 
components were subdivided into the following categories (see Figure 2.6): 
 Main structural components – Plastic or aluminium. These connect, locate and support the 
motors and other components and provide a framework and base upon which to stand 
 Force sensing elements – Aluminium. Fitted with strain gauges for the purposes of measuring 
load applied to them (i.e. force transducers). 
 Interface elements – Aluminium. These directly interface with the participant, lined with 
foam rubber for comfort 
 
Parts of the base and main structural components were fabricated of poly(methyl methacrylate) – also 
known as PMMA, or as its trade name „Perspex‟ – to be in line with the design philosophy of using 
plastic components where possible. The force transducer elements and interface elements, however, 
were fabricated of aluminium due to space limitations necessitating compactness and strength. All 
surfaces that interfaced with the participant were coated in soft foam for comfort. 
The flow diagram for the integration of these components is shown in Figure 2.5. 
 
 
Figure 2.1 Convention for specifying joint rotational position and velocity. 
Positive wrist and finger 
angle rotation (flexion) 
Negative wrist and finger 




Figure 2.2 Overview of all components making up the system: (A) Mechanical 
components of the system (i.e., „the device‟), (B) data logger for USB for 
connection to PC, (C) cables for EMG electrodes, (D) safety buttons, (E) 
power input, (F) main control box housing electronic components (except 












Figure 2.3 The neutral position of the device (wrist at 0°, fingers at +45°) illustrating 
how the participant‟s hand was secured.  
 
 
Figure 2.4 Back view of device, illustrating the enclosure housing the strain gauge 








Figure 2.5 Functional overview of the components of the system (power management 









































Strain gauge amplifier circuit 
board1 
1 – See Section 2.4 
2 – See Section 2.3 






Figure 2.6 Exploded view of structural, force transducer and interface components of 
the device finger joint (some components have been omitted for clarity of 
illustration).  
 
2.2.2. Torque and Speed Specifications 
The finger and wrist joint actuators were identical – geared, brushed DC electric motors. The use of 
somewhat limited motor power was intentional, for participant safety. It was recognised that the joint 
velocity might fluctuate due to resistance from participants when using motors of limited power. 
Participant safety was a priority, however, and more powerful motors would have introduced a 
substantial risk. 
Two types of motors were used at different points in the study. With the slower motors, a maximum 
rotational speed of both the finger and wrist joints (after power transmission through the gear train) 
was 4.4 rpm (26.6°/s), and the rated torque at these joints was 1.32 N.m. With the faster motors, the 
maximum speed of each joint was 9.6 rpm (57.8°/s) and the available torque of each was 4.0 N.m. 











2.2.3. Safety Features 
Safety was a priority in the design of each element of the system. Safety features primarily guarded 
against application of excessive torque to the participant‟s hands, but also against device 
malfunctions, hyperextension, and electric shock. These safety features are discussed here.  
Two safety buttons were included in the design. These were simple push-buttons mounted on a handle 
(see Figure 2.2 and Figure 2.5). These buttons were required to be held to enable device movement. 
The buttons were operated by the participant as well as by the examiner. If either became 
uncomfortable with the any aspect of using the system, the button could be released and movement 
would immediately cease. 
The method of implementation of the safety buttons was twofold: when a button was released, 
software algorithms (microcontroller implemented) as well as hardwired electronics (L298 dual 
bridge driver) ceased power to the motors (see Figure 2.7). For the latter the safety buttons were 
connected to the „enable‟ pins of the L298 IC. By releasing the button the enable pins were pulled low 
thereby deactivating the motors‟ power source.  
Features guarding against hyperextension included the mechanical stops (see Figure 2.8). The various 
structural elements were designed such that they physically obstructed rotation of the joint beyond the 
defined limits. This was designed to guard against the event that the limit switches fail to cease 
movement. 
The mechanical range was pre-determined and not adjustable in this prototype. The finger joint‟s 
mechanical stops engage to only allow motion between 0° and +90°, and the wrist‟s mechanical stops 
engage to only allow motion between -45° and +90°. Although the actual limits of operation of the 
wrist in practice were narrower due to the use of electrical limit switches (see Figure 2.9). The limit 
switches limited operation of the wrist to between +70° to -35°.  
Certain design choices were also motivated by safety. As stated in Section 2.2.2, the motor torque was 
deliberately limited even though this may have slightly affected rotational speed of the joints against 
varying resistance. Also, electrical limit switches were necessary to cut motor power when the ranges 
of motion had been reached. The choice to wire them such that engaging the switch opened the circuit 
(rather than closing it) was made with safety in mind: a faulty connector or broken wire would not 
maintain voltage to the microcontroller. This potentially dangerous fault would not be detected if the 





Figure 2.7 Diagram illustrating how handheld safety buttons have redundancy in how 
they interrupt motor power.  
 
2.3. EMG Signal Acquisition and Processing 
An EMG signal acquisition system was included such that muscle activity could be recorded during 
tests. The observed EMG would be useful for distinguishing between neural and non-neural joint 
resistance (see Section 1.1.1). Non-neural joint resistance (such as due to soft tissue changes) would 
not be accompanied by electrical muscle activity. EMG data was useful to aid interpretation of the 
force data collected during the pilot clinical trials. 
EMG was acquired using a bandwidth-modified version of the open source Modular-EEG boards 
(“The OpenEEG project,” 2013). See Appendix B for details about the OpenEEG boards, and 
Appendix C for details about the bandwidth modifications made. 
The signal produced by the OpenEEG amplifier board was recorded by the DAQ without any 
alteration. It was also processed by a dedicated circuit board before being sent to the microcontroller 
(see Figure 2.5). 
This EMG signal processing was performed with analogue electronics. It consisted of the following 











pins on motor 
driving IC. 
Device control unit 
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 Additional high-pass filtering of the signal with a cut-off frequency of 7.3 Hz to remove low 
frequency components such as motion artefact. 
 Rectification of the signal using a precision rectifier to avoid loss of information 
 Peak detection to provide an „envelope‟ for microcontroller processing.  
 
 
Figure 2.8 CAD images showing a top view of selected structural components 
indicating how hyperextension blocks limit range of motion: (A) device 
finger and wrist joints at 0°, (B) device finger joint at 90° and wrist joint at 
0°, (C) device wrist joint at -45° and finger joint at +45°, (D) device wrist 




Four separate channels of EMG were available to be recorded, each connected to a dedicated 
analogue input pin on the microcontroller. In software, the analogue EMG signals were compared to 
the voltage set by user-controlled EMG activation threshold adjustment potentiometers to determine 
when a muscle was deemed active. 
 
Figure 2.9 Limit switches for wrist flexion and extension, engaged when wrist was 
flexed to +90 degrees or extended to -35 degrees respectively.  
 
 
Figure 2.10 Analogue EMG signal processing performed by the dedicated analogue 
EMG processing circuit board  
 
For this comparison of EMG to the threshold, a double threshold system was applied to the EMG 














electronic circuit known as a Schmitt trigger (see Horowitz and Hill, 1989). For the output to change 
from low to high, the EMG envelope must exceed the higher of two thresholds. However, in order for 
the output to return to the low state, the input must drop below the lower threshold. This prevented 
chatter which is observed in a single-threshold system. The upper threshold was set by the user by 
adjusting the threshold adjustment knobs on the control box. The lower threshold was set in software 
to be 20% of the upper threshold setting, which was decided following experimentation with different 
values. The end result of the analogue EMG signal processing was a boolean value for each muscle, 
with the high value indicating activity. The microcontroller uses the processed EMG data to determine 
which joint gesture is being attempted by the participant, and react accordingly (see Table 2.1). If the 
wrist flexor muscle being monitored (flexor carpi radialis) was deemed active, the wrist joint on the 
device was rotated. Similarly, if the wrist extensor muscle (extensor carpi radialis longus) was 
deemed active, the device‟s wrist joint was extended. If both were deemed active no action was taken. 
This was because, in a biomechanical sense, the co-contraction of agonist and antagonist muscles acts 
to stabilize a joint and no net rotation is produced.  
Similarly, if the finger flexor muscles were deemed active, then the wrist extensor muscle EMG was 
ignored. This was because, if contracted in isolation, the finger flexor muscles also have a moment 
arm at the wrist joint. If only finger flexion is desired, then wrist extensor muscles are recruited to 
stabilize the wrist joint and a small amount of wrist extensor EMG is seen during finger flexion. 
Similarly, if finger extension muscles were deemed active, wrist flexion EMG was ignored. 
 
2.3.1. EMG Safety Features 
Important safety features formed integral parts of the modified OpenEEG boards. These include 
optical isolation, for example, to isolate and protect the participant from current surges in the event of 
electronic failure. 
Safety was also a factor when developing the experimental protocols which included EMG data 
collection. For example, the data collection electrodes should always be placed on the same limb as 
the noise cancelling ground electrode (also known as the DRL electrode – see Section 3.2.1). If one 
were to collect EMG data of a muscle on the contralateral arm to the ground electrode, the potential 
exists for a fault to allow electrical current to pass through the heart. This, while extremely unlikely, 
could be a potentially lethal event and all precautions should be taken to guard against it. 
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Table 2.1 Truth table for sensed EMG and joint activity 
wrist extensor wrist flexor finger extensor finger flexor Deemed activity: 
0 0 0 0 no activity 
1 0 0 0 wrist extension 
0 1 0 0 wrist flexion 
1 1 0 0 no activity (wrist stabilized) 
0 0 1 0 finger extension 
0 0 0 1 finger flexion 
0 0 1 1 no activity (fingers stabilized) 
0 1 1 0 finger extension only 
1 0 0 1 finger flexion only 
 
2.4. Force Transducers and Associated Electronics 
The force sensing elements were fabricated from 1050-H14 sheet aluminium. The thickness was 
selected such that a measurable strain would be produced when the expected force was applied 
(estimated to be 30 N). The calculations for the thickness are presented in Appendix A. 
Four strain gauges were adhered to the force sensing elements, into which the wrist and the finger 
interface elements transmitted force, and each strain gauge set was in a full bridge configuration, 
arranged to detect bending loads. The output of each bridge was amplified in analogue electronics 
(see Figure 2.11) before being recorded by the DAQ. 
The amplifier circuit used an INA114BP instrumentation amplifier integrated circuit (IC) with a gain 
of 76.8 (660Ω external resistor, RG, used for gain selection - see Figure 2.11 and Appendix B). A 
potentiometer was used for DC offset adjustment. The output voltages were not set to zero, but rather 
a reference voltage of approximately 2 V so that the output may swing „negative‟ to indicate forces in 
the extension direction. This offset was later digitally subtracted. 
 
All operations performed in the calculation are linear. The output voltage was to be expected to be 




Figure 2.11 Schematic diagram of a strain gauge gauge amplifier circuit. Identical 
circuits were used for the wrist and finger force transducers (see Figure 2.5). 
 
Certain factors could have affected the relationship, however, such as electronic component or part 
manufacturing uncertainty, the “toe” region in the stress-strain curve of the sensing element material. 
In light of these factors, a calibration was performed to determine the actual voltage response to 
applied force (see Appendix A) for details of the calibration process. The calibration curves are shown 
in Figure 2.12. 
 
2.5. Data Logging and PC Software 
PC software was required to record, process and display data in real time. All PC software for data 
logging was written using National Instruments Labview by Dr. Lester John of the University Of 
Cape Town Department Of Human Biology, Biomedical Engineering Division.  
The data logger used in the system was a 12-bit National Instruments DAQ, which sampled at 10 kHz 
and interfaced with a PC by USB. Only data logging was performed by the DAQ because later 
prototypes of the system might need to perform all functions independently. PC based control of the 




Finger Joint Transducer Calibration Curve 
 
Wrist Joint Transducer Calibration Curve 
 
Figure 2.12 Force amplifier calibration curves showing measured amplifier output for 
applied load to the interface components of the device‟s finger joint (top) 
and wrist joint (bottom). Loads were applied in steps to the interface 
components and the relevant voltage was recorded. Positive loads indicate 
that they were applied in the flexion direction (in keeping with the 
convention). Also shown are linear trend lines using the least squares 
method, with the equation and R2 values shown. The trend line was 
constrained to pass through the origin, since the data was zeroed in post-
processing. Loading and unloading curves show minimal hysteresis and 
trend lines take both loading and unloading into account. For more 
information on the calibration, see appendix A.  
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The sampling rate of data logging was 1000 Hz. The following values were recorded: 
 Elapsed time since the beginning of the recording 
 4x EMG data channels 
 2x participant force data channels 
 2 x EMG threshold data channels 
  
During the clinical tests it was useful to be able to visualize these recorded values in real time. 
Graphical user interface (GUI) software was written to accompany the data logging software (see 
Figure 2.13). 
The GUI contains real time plots of a short time window of EMG and force data, with the EMG 
activation threshold overlaid onto the EMG plots. The GUI also contains text fields for input of 
participant information and notes about the current recording. The GUI also featured control elements 
such as clickable pushbuttons to begin and terminate recordings, etc.  
Data was stored in text files on the PC hard drive. These were later imported into Matlab for data 
processing (see Section 3.3). 
 
Figure 2.13 Screenshot of the GUI. (A) Text fields for patient details and user comments. 
(B) Clickable button to begin or terminate a recording. (C) EMG plot areas. 





















2.6. Modes of Operation 
The device had the ability to operate in two modes, named the „evaluation mode‟ and „EMG mode‟.  
In evaluation mode the device would passively manipulate the participant‟s hand through prescribed 
motions while involuntary resistance was recorded.  
When operated in EMG mode, the system used the EMG data acquisition system (see Section 2.3) to 
move the device joints in response to participant volition. If the EMG envelope signal exceeded the 
activation threshold, the device would respond by manipulating the appropriate joint.  
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This chapter outlines the experimental procedures that were carried out, as well as precautions that 
were taken.  
3.1. Methodology Overview 
Figure 3.1 illustrates a graphical overview for the methodology, indicating various stages of apparatus 







Figure 3.1 Overview of the various phases of development and testing of the system, 
indicating how the design was modified as progress occurred. 
 
The study consisted of a preliminary safety test followed by the pilot clinical trial (see Figure 3.2 and 
Figure 3.3). The participants in the preliminary safety test were healthy adults, while those in the pilot 
trial had histories of mild to moderate hypertonia of the hand and wrist. Participants in the pilot trial 
were assigned pseudonyms “Participant A”, “Participant B”, etc., to protect anonymity.  
The study began with the preliminary safety tests, in which the system was used in EMG mode. 
Participants were asked to contract certain muscles with the goal of effecting specific actions of 
flexion and extension of the corresponding device joints. For ethical and safety reasons, participants‟ 
interactions with the device during this phase were intentionally limited. Participants were not 
strapped into the device but rather were only fitted with the EMG electrodes for electrophysiology 
data acquisition (see Section 3.2.1 for the detailed experimental procedure). The outcomes of these 
tests were largely qualitative (see Section 4.1), demonstrating the ability of the device to perform the  
Initial system development 
Preliminary Safety Test 
Design modifications 




intended tasks safely and verification that features operated as intended, especially the safety features 
as outlined in Section 2.2.3. These tests also demonstrated that the system could use EMG as a control 
input to flex/extend the fingers/wrist, thereby demonstrating the potential use of the device as a task-
oriented therapy tool. Further development in this regard is beyond the scope of this research, 
however, and is discussed as a recommendation for future work (see Section 5.3). Following the 
preliminary safety tests, areas for design improvement were identified and modifications were 
implemented (see Section 3.2).  
The pilot trial was conducted once these modifications had been implemented (see Section 3.2.2 for 
the detailed experimental protocol). The system was tested with 6 participants with varying levels of 
hypertonia (MAS scores raging between 0 and 3). The device manipulated the participant‟s hand 
while their involuntary resistance to passive motion was recorded. For the first three tests the finger 
 
 
Figure 3.2 Image illustrating the experimental setup for the preliminary safety tests. The 
examiner (A) and the participant (B) are seated at a table. Both are holding 
the safety buttons (C and D) while the participant performs talks of wrist 
and/or finger flexion (E). EMG activity is measured (F), and results in 











Figure 3.3 Image illustrating the experimental setup for the pilot clinical trial. The 
examiner (A) and participant (B) were seated at a table. Both were holding 
the safety buttons (C and D). If necessary, a supervising therapist would hold 
the participant‟s safety button for him/her.  
 
joint was extended, followed by the wrist joint. A problem encountered during these tests, however, 
was that the participant‟s fingers were slipping out place as the device finger joint was moved. Finger 
manipulation was therefore abandoned from the testing protocol for the remainder of the tests, and 
only wrist manipulation was performed for subsequent tests. Following the second test, it was further 
decided that EMG data would be advantageous to collect. EMG recordings for the wrist flexor (flexor 
carpi radialis) muscle were collected for the last four tests. 
Offline force and EMG data processing was performed in Matlab to filter and remove any artefact 
associated with electromagnetic interference (EMI). For EMG, this consisted of applying a 50 Hz 
notch to remove excessive electrical noise from the mains, as well as processing to compute EMG 
amplitude before amplification. The latter involved spectral scaling to correct for the gains of the 
EMG amplifiers. The gains were frequency-dependent so spectral scaling was implemented (see 










3.1.1. Participants Inclusion/Exclusion Criteria 
Participants in the preliminary safety test were all adult volunteers: 13 male and 2 female, average 
25.4 ± 2.7 years old, recruited from among the staff and students at the University of Cape Town‟s 
Department of Human Biology. 
The participants in the pilot clinical trial were all adult volunteers: 2 males, 4 females, average age 
51.33 ± 22.9 years. Participants were recruited from the among the patients at the Departments of 
Physiotherapy and Occupational Therapy at Groote Schuur Hospital, as well as from Life Vincent 
Pallotti Hospital, both in Cape Town. The participants had a history of hypertonia in either the left or 
right hand. One healthy male individual was included with the six volunteers. Recorded MAS scores 
are presented in Table 4.2. 
The inclusion criteria were as follows: 
 All must be 18 years of age or older 
 All must have must have read, understood and completed the consent form 
 For the preliminary safety test only, all were required to be in good health and have no history 
of any disorder affecting the use of either hand/wrist. 
 For the pilot trial, all were required to have a MAS score of 3 or less, as rated by a clinician 
prior to testing 
 All were required to have sufficient range of motion of the fingers and wrist joints: 
o Wrist joint range of motion: +70° to  -35° 
o Finger joint range of motion: 0° to +90° 
The exclusion criteria were as follows: 
 None may have any history of diseases that could compromise safety. Each case was be 
assessed individually, both by the researcher and by a clinician present at testing. Examples of 
excluding conditions are: 
o Osteoporosis or arthritis of the affected hand 
o Pain during finger/wrist joint manipulation 
o Contractures 
o Tendonitis of the hand or wrist tendons  
o Carpal tunnel syndrome  
o Altered sensation and/or proprioception may or may not constitute exclusion, at the 
discretion of the researcher and physician 
 No cognitive disorders or impaired communication capacity for any reason 
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3.1.2. Muscles for EMG acquisition 
The muscles that were monitored during the study are shown in Table 3.1.  
Table 3.1 Summary of the actions of the muscles monitored in both the 
preliminary safety tests and the pilot trial 
Muscle Primary Actions 
Phases of testing in 
which muscle was 
monitored 





Flexion of the middle phalanges at 
the proximal interphalangeal joint. 
Under continued action, it also flexes 
the metacarpophalangeal joint and 
wrist joint. 




Extension (and also abduction) of the 
wrist joint. 
Preliminary safety test 
Only 
Extensor digitorum Extension of the phalanges. Preliminary safety test 
Only 
 
3.1.3. Design Modifications Following the Preliminary Safety Test 
Modifications to the system were made based on the observations noted in the preliminary safety 
tests. After reviewing performance, clinical collaborators were concerned that the device movement 
was too slow to elicit a stretch response. The maximum device joint velocity was 26.6°/s. A faster 
variant of the motors was installed, increasing the velocity to 57.8°/s (see Section 2.2.2). However, 
following the first three tests, there were new concerns that discomfort could have been inflicted on 
the participant before either safety button could be released. The system was not unsafe, but had the 
potential to cause discomfort. It was decided that the original, slower motors would be reinstalled to 
mitigate risk since it was now clear that the slower motors would be sufficient for the task (see 
discussion of this in Chapter 5.2.2). 
Other alterations to the system were relatively minor: 
 The EMG cable lengths were lengthened to provide more freedom of movement. 
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 The design was modified to be used with the left or right hand. In order to achieve this, a 
frame system was included to allow the device to be turned upside down. In addition, the 
interface elements that interact with the palm were modified to accommodate the thumb 
appropriately. 
 The strain gauge amplifier circuitry was relocated to be housed on the device itself, rather 
than in the control box. This was motivated by noise due to EMI that was introduced in the 
cables between the device and the amplifier circuitry, despite the use of shielded cables. Once 
the circuitry was relocated, the cables were significantly shorter and this excessive noise 
contamination was no longer observed. 
 The system was modified to record raw EMG in the pilot trial, instead of the EMG amplitude 
envelope. 
 
3.2. Detailed Testing Protocols 
3.2.1. Preliminary Safety Test 
See Figure 3.2 for an illustration of the experimental setup for the preliminary safety test. The 
protocol was as follows: 
1. The system was set up on a table. The system had been initialized in advance for use in EMG 
mode (see Section 2.6). A video camera was set up to record only the participant‟s arm and no 
personal identifying features were recorded. This was in accordance with the requirements for 
Human Research Ethics Clearance (see Appendix G). 
2. The objectives and details of the test were briefly explained. If the participant agreed, then the 
consent form was signed (see Appendix G) and the test proceeded. 
3. The EMG electrode placement sites (see Figure 3.4 and Figure 3.5) were over the following 
muscle bellies of the right arm: flexor carpi radialis, flexor digitorum superficialis, extensor 
carpi radialis longus, extensor digitorum. An additional electrode was to be placed over the 
medial epicondyle of the humerus (i.e. a bony landmark on the body), as the active common 
mode noise cancelling ground electrode, typically referred to as a “driven right leg” or DRL 
based on terminology from electrocardiology. Note that for the preliminary safety tests, the 
right arm was used. In the pilot trial, however, the arm that was affected by increased tone 
was used. The ground electrode was always placed on the same arm as the other electrodes. 
4. The areas where self-adhesive EMG electrodes would be attached were prepared by carefully 
abrasion to remove the top layer of the skin. The area was cleaned using an alcohol swab to 
remove natural skin oils. The EMG electrodes were then placed for bipolar EMG recording. 
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The inter-electrode distance was 20mm, and the contact impedance for each electrode pair 
was measured, and confirmed to be below 10 kOms per electrode pair, as is recommended by 
Fridlund and Cacioppo (1986) (see Figure 3.4 and Figure 3.5). 
5. The participant was asked to contract the various muscles without holding the safety buttons, 
in order to confirm that these buttons were functional (i.e. no device movement was 
produced). This safety check was performed despite the participant not being strapped into 
the device. The same was repeated while the safety buttons were being held to observe that 
the device responded to EMG. 
6. The participant was then asked to contract the various muscles while holding the safety 
buttons. The EMG threshold adjustment knob was used to find comfortable muscle activation 
thresholds. These thresholds were used to make only simple inferences of muscle activity in a 
binary fashion („active‟ or „not active‟). The exact level of the threshold depended on 
participant comfort. A comfortable threshold was one that was high enough that it wasn‟t 
accidentally exceeded by system noise or disturbances (i.e. motion artefact), but low enough 
that the participant could easily elicit an action in the device. 
7. At this point, the test could begin. The video recording was initiated.  
8. The participant was asked to perform three different tasks of flexion and extension, while a 
video recording of the test was captured for later review. The three tasks were as follows: 
 Five repetitions of flexion and extension of the device finger joint, without moving the 
device wrist joint if possible 
 Five repetitions of flexion and extension of the device wrist joint, without moving the 
device finger joint if possible 
 Five repetitions of flexion and extension of the device wrist and finger joints 
simultaneously 
9. The video recording was terminated. 
10. The device was turned off and the electrodes were removed. The test was complete.  
 
3.2.2. Pilot Clinical Trial 
See Figure 3.3 for an illustration of the experimental setup for the pilot clinical trial. The protocol was 
as follows: 
1. The system was set up on a table. The system had been initialized in advance for use in 
evaluation mode.  
2. As with the procedure for the preliminary safety tests, a brief introductory discussion with the 
participant was held prior to testing. The purpose of the study was discussed, and all the 
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safety features were described (see Section 2.2.3). If the participant agreed, then the consent 
form was signed (see Appendix G) and the test proceeded. This discussion, while necessary in 
terms of regulations regarding human research ethics, was also important for calming the 
participant and relieving anxiety since psychological factors can aggravate hypertonia.  
3. Assessments by three physiotherapists or occupational therapists were performed to 
determine the wrist flexor MAS score. Each rater was blind to the others‟ results. 
4. EMG activity of the wrist flexor muscle, flexor carpi radialis, was recorded for all tests 
following Participant B (see Table 3.2). Skin preparation and EMG electrode placement was 
performed as for the preliminary safety tests (see Section 3.2.1). Note that the test was 
performed with the arm affected by hypertonia. Furthermore, for the tests for which EMG 
was recorded, electrodes were only placed over the flexor carpi radialis muscles and medial 
epicondyle of the humerus. This was unlike the preliminary safety tests which also included 
EMG recording of the flexor digitorum superficialis, extensor carpi radialis longus and 
extensor digitorum muscles, and were always performed with the right arm.  
5. The EMG cables from the control box (see Figure 2.2) were attached to the electrodes. The 
participant was asked to contract the target muscles so that EMG signals were displayed on 
the GUI on the computer screen (see Figure 2.13). 
6. The strain gauge offsets were adjusted until the signals were approximately mid-range (2V in 
the 0V – 5V system). The precise offset was unimportant, as these would later be zeroed in 
software (See Section 3.3.2). 
7. The participant‟s hand was placed into the device and the straps were secured.  
8. The test commenced. The participant was asked to relax and to hold the safety button with 
their unaffected hand while the test was in progress. If necessary, the safety button was held 
by a supervising clinician. The examiners safety button was also held. The initial protocol 
included evaluation of the finger and wrist joints, although it was found that the participants‟ 
fingers were slipping out when the device finger joint was moved. After Participant C, finger 
manipulation was excluded from the protocol (see Table 3.2). The precise set of prescribed 
movements were as follows: 
a. For protocols included finger and wrist manipulation, the starting position was with 
both joints straight (0°). The protocol was as follows (see Figure 3.6): 
i. The device flexed its finger joint from the starting position (0°) to full flexion 
(+90°) in preparation for the test. 
ii. The fingers were extended from +90° back to 0°. 
iii. The finger joint was then flexed from 0° back to +45° to allow for 
comfortable manipulation of the wrist joint (simultaneous full extension of 
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both the wrist and finger joints can cause discomfort in participants with 
moderate hypertonia).  
iv. The wrist joint was flexed from the starting position (0°) to +70°.  
v. The wrist joint was extended through the full range of motion from +70° to -
35°.   
vi. The wrist was flexed back to the starting position (0°). 
vii. The finger joint was extended from +45° to the starting position (0°). 
b. For protocols including only wrist manipulation, the starting position was with the 
wrist straight and with the fingers flexed to +45°. The protocol was as follows: (see 
Figure 3.7): 
i. The wrist joint was extended from the starting position (0°) to -35°.  
ii. The wrist joint was flexed from -35° to +70°.   
iii. The wrist joint was extended from +70° to -35°.   
iv. The wrist joint was flexed from -35° to the starting point (0°).   
9. Three repetitions of step 7 were performed with each participant, although only the data from 
the last repetition would be recorded and used for analysis. A similar approach is taken by 
clinicians when performing traditional MAS assessments (see Section 1.1.5).  
10. Once the last repetition had been performed, data recording was terminated. The participant‟s 
hand was removed from the device. 
11. The device was turned off and the electrodes were removed. The test was complete.  
 
The various combinations of speed and/or testing protocol were used are summarised in Table 3.2. 
Table 3.2 
Summary of testing protocols in the pilot trial, indicating EMG data 
collection, finger and/or wrist protocol, and joint speed 
combinations. Note the change in joint speed that was 
implemented after Participant C when the original, slower 
motors were reinstalled. 
Participant: A B C D E F 
EMG collected: No No Yes Yes Yes Yes 
Fingers/Wrist 















26.6°/s   
(1.32 
N.m) 
26.6°/s   
(1.32 
N.m) 








Figure 3.4 The positions of bipolar EMG electrodes monitoring selected muscles in the 




Figure 3.5 The position of bipolar EMG electrodes monitoring selected muscles in the 
flexor compartment of the forearm, as well as the DRL electrode: (a) flexor 
digitorum superficialis, (b) flexor carpi radialis, (c) ground on the medial 





















Figure 3.6 Flow chart illustrating the various prescribed movements for the protocol 





(i) Flex fingers to 
+90° 
 
(ii) Extend fingers 
to 0° 
 
(iii) Flex fingers to 
+45° 
 
Finger manipulation  
(iv) Return to starting position  
(iv) Flex wrist to 
+70° 
 
(v) Extend wrist to 
-35° 
 
(vi) Flex wrist to  
0° 
 



















Figure 3.7 Flow chart illustrating the various prescribed movements for the protocol 
including only wrist manipulation. 
 
 





(i) Extend wrist to  
-35° 
 
(ii) Flex wrist to 
+70° 
 
(iii) Extend wrist to 
-35° 
 
Wrist manipulation  
55 
 
3.3. Data Processing 
3.3.1. Preliminary Safety Tests 
The preliminary safety tests served as a demonstration of the various features of the device. The 
outcomes were largely qualitative (see results in Section 4.2). Observations regarding potential design 
modifications were noted (see Section 3.2), and it was verified that no unexpected behaviour of the 
device occurred, and that all safety features functioned as intended. To extract quantifiable data from 
the tests, the video recordings of the tests were reviewed. The times to complete the various 
repetitions of each of the tasks were noted (see Section 4.1). 
 
3.3.2. Pilot Clinical Trial 
EMG and force data were processed in Matlab. This was automated using scripts, the corresponding 
code for which is presented in Appendix F. The procedure for processing of the EMG data is 
presented in Appendix E. 
Note that a part of the code is dedicated to the removal of what is referred to as „force drift‟. It was 
found that, when the device was operated without a participant‟s hand secured, force readings were 
registered even though no external force was applied. Force recordings obtained when operating the 
device without a participant secured clearly depicts the force drift (see Figure 3.8). Ideally, such 
recordings would reflect no activity. The main causes of this noise were EMI from the motors as well 
as shifting weight as the device joints moved. The latter caused a redistribution of the stress in the 
force transducer components which manifested as artificial readings.  
The low frequency component of this artificial force reading was highly repeatable (Figure 3.8 shows 
repeat recordings), and so digital subtraction from the final data was possible (see Figure 3.9). The 
higher frequency noise, also due to EMI from the motors, was filtered using a low pass filter. The 
signal associated with applied force was expected to be of relatively low frequency. It was found that 
a cutoff frequency of 200 Hz was effective in removing EMI while preserving the components of the 
signal associated with applied force.  
The high frequency noise component (that was removed) was also used to infer the activity of the 
motors for the purposes of segmenting the data: by observing the noise due to motor activity, and with 
knowledge of the programmed sequence of device joint actions, the specific action being carried out 







Figure 3.8 Plot illustrating the repeatability of the drift observed in the force readings 
with device joint movement. Three plots of different force readings for wrist 
transducer were obtained during “evaluations” performed without a 
participant secured into the device. (i) extension of the device wrist joint 
from 0° to -35°, (ii) flexion of the device wrist joint from -35° to +70°, (iii) 
extension of the device wrist joint from +70 to -35°, (iv) flexion of the 
device wrist from -35° to 0° (see Figure 3.7). Note the drift in the reading, as 
well as the “stop/start” artefact introduced due to the pauses which occur 
roughly at t=3.5s, t=9s and t=15s. The drift is highly repeatable, and it was 
possible to subtract it from recorded force data from the pilot trial (see 
Figure 3.9). This digital subtraction was performed in offline in software. 
 
i ii iii iv 
i ii iii iv 




Figure 3.9 Plot illustrating the effectiveness of digital subtraction to correct for artificial 
force drift. The plot shows the corrected force reading for the wrist 
transducer obtained during an “evaluation” performed without a participant 
secured into the device (see Figure 3.8). Correction was performed by 
digitally subtracting the average of the three readings shown in Figure 3.8. 
(i) extension of the device wrist joint from 0° to   -35°, (ii) flexion of the 
device wrist joint from -35° to +70°, (iii) extension of the device wrist joint 
from +70 to -35°, (iv) flexion of the device wrist from -35° to 0° (see Figure 
3.7).  
 
The Matlab code, executed separately for each participant‟s recording, performed the following tasks 
(in order): 
1. The following data was imported: 
 Force data recorded during tests with participants 
 The force data from an identical test, recorded without a participant strapped into the 
device (referred to as the force drift data) 
2. The force baseline was calculated as being the average of the first 1000 milliseconds of the 
recording. This was subtracted from all recordings for that test, such that the force data was 
zeroed (see the experimental protocol in Section 3.2.2), specifically step 5, stating that the 
force recordings would be digitally zeroed in post-processing. Note that this step is for the 
removal of DC offset in the force recordings, and is not to be confused with the removal of 
force drift (performed in step 6). 
3. The time markers for the various stages of the prescribed motion were identified for both the 
test data and the force drift data. This was performed by analysing only the high frequency 
component of the data. From EMI noise observed, it could be determined when the motors 
i ii iii iv 
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were engaged and disengaged. Using these time markers, various data segments were 
identified, referred to a „phase i‟, „phase ii‟, etc. 
4. The data was cropped to discard information occurring outside of the time window of interest: 
2 seconds before the test began till 2 seconds after it was terminated. 
5. Each segment of the prescribed motion in the average force drift data was resized such that it 
temporally matched the corresponding segment in the test data. 
6. The average force drift was subtracted from the test force data (see Figure 3.8). 
7. The recorded force data (in volts) was transformed into Newtons using the calibration data 
(see Figure 2.12). 
8. The data was cropped such that only the relevant segment of the test (i.e. the wrist extension 
phase) was included. 
9. The peak measured resistive wrist force was determined, as well as the simultaneously 
occurring finger force (see Table 4.1). This data would be used in the biomechanical model 
(see Section 3.4). 
10. The data presentation (plots, etc.) was prepared (see Figure 4.4 to Figure 4.11). 
3.4. Biomechanical Model 
In addition to the signal processing performed on the data collected in the pilot trial (Section 3.3.2), a 
biomechanical model was implemented to estimate the tensions in the wrist for use in statistical 
analysis. The following section outlines the biomechanical model used, whereby the tensions in the 
wrist and finger flexor tendons could be calculated. The model used only the torques at the finger and 
wrist joints during passive wrist extension as inputs. 
The model begins with a force diagram, depicting the geometry of the system and relative forces 
applied (see Figure 3.10). 
It is assumed that all joint velocities were slow enough that inertial effects could be ignored, and that 
the system existed in a state of static equilibrium. Consider a participant applying forces Ff and Fw. 
These are measured by the transducers, which also equal but opposite forces onto the participant‟s 











Figure 3.10 Illustration of the participant‟s hand (top) as well as force diagram for the 
biomechanical model (bottom). Point A corresponds to the finger (MCP) 
joint, and point B corresponds to the wrist joint. Ff and Fw are the forces 
applied to the finger joint force transducer and wrist force transducers 
respectively. The distances df, df,f and dw are due to the geometry of the 
device design (see Figure 3.3). 
 
From the force diagram one can determine MA, the internal moment at the participant‟s finger joint 
due to Ff, as follows: 
           
The moments applied to the finger and wrist joints respectively must balance, since the system is in a 
state of static equilibrium. The moment MA  is balanced by tension in the participant‟s finger flexor 
tendons. This tension can be calculated with knowledge of the tendon moment arm at the MCP joint. 
In their text on clinical mechanics of the hand, Brand and Hollister (1999) used the approximate 
values shown in Figure 3.11. These values are likely to vary between subjects, but serve as an 





dw = 0.060 m 
df = 0.120 m 







Figure 3.11 Illustration of the various moment arms that finger flexor tendons possess at 
the various joints. Left to right: distal interphalangeal joint (0.05 m), middle 
interphalangeal joint (0.075 m), proximal interphalangeal joint (0.01 m), and 
the wrist joint (0.0125m). (Brand and Hollister, 1999) 
 
The balance of moments at the MCP joint can be expressed mathematically as follows: 
                                  
The symbols Ftendon,finger and dtendon,finger respectively represent the tension in the finger flexor tendons 
and the moment arm that the finger flexor tendons have at the finger joint (shown in Figure 3.11 to be 
1.0cm). It follows that: 
               
  
              
 
 
       
              
 
(Equation 3.1) 
The internal moment MB at the wrist joint due to the applied forced Ff and Fw can be expressed as 
follows: 
         (         )     
(Equation 3.2) 
MB is again balanced by the tension in tendons at that joint. The wrist and finger flexor tendons both 
have moment arms at the wrist joint. This balance of moments at the wrist joint can be expressed 
mathematically as follows: 
   (                           )               
(Equation 3.3) 
The symbols Ftendon,wrist and dtendon,wrist respectively represent the tension in the wrist flexor tendons and 
the moment arm that the wrist flexor tendons have at the wrist joint. It will be assumed that the wrist 
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flexor tendon has the same moment arm at the wrist as the finger flexor tendon, shown in Figure 3.11 
to be 1.25cm. 
Rearranging, we have:  
             
  
            
                
(Equation 3.4) 
Substituting Equation 3.1 and Equation 3.2, the tension in the wrist flexors can be determined: 
             
      (         )    
            
 
       
              
 
(Equation 3.5) 
Substituting known or estimated values for dw, df, dtendon,wrist, and dtendon,finger, we can show that: 
                            
(Equation 3.6) 
By applying Equation 3.6 with data recorded in the pilot trial (using the peak recorded force in the 
wrist transducer during wrist extension as Fw, and the co-occurring force measured by the finger 
transducer as Ff), the peak tension in the wrist tendon during wrist extension was calculated.  
3.5. Precautions 
This section details the precautions taken during the test procedures, to ensure patient safety and to 
protect the integrity of the results: 
 
3.5.1. Preliminary Safety Test 
 Participants were asked to refrain from moving excessively during the tests, to prevent motion 
artefact in the EMG recordings. 
 The ground electrode for EMG recordings was always placed onto the same arm as the other 
EMG electrodes to prevent accidental discharge of electrical current across the heart. 
It was ensured that the EMG electrodes were not touched once the test had begun, to avoid the 
introduction of noise. 
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3.5.2. Pilot Clinical Trial 
 A careful assessment of the participant‟s hand was performed to ensure that the inclusion 
criteria were satisfied (see Section 3.1.1) – especially the range of motion requirements. 
 Participants were asked to refrain from moving excessively during the tests, to prevent motion 
artefact in the EMG recordings. Care was taken to ensure that the participant understood not 
to attempt voluntary movement during a test, since only passive (involuntary) resistance was 
of interest. 
 The ground electrode for EMG recordings was always placed onto the same arm as the other 
EMG electrodes to prevent accidental discharge of electrical current across the heart. 
 As for with the preliminary safety tests, it was ensured that the EMG electrodes were not 
touched once the test had begun, to avoid the introduction of noise. 
 Care was taken to ensure that the participant was comfortably seated and positioned before 
the test began, because if he/she moved or shifted excessively during the test, it may have 
introduced motion artefact into the force and EMG recordings. 
 Immediately before the test was initiated, it was ensured that the participant‟s thumb was not 
flexed and/or opposed, because it would obstruct motion of the hand during finger flexion. It 










This section details the results of the experimental protocols outlined in Chapter 3. Section 4.1 
presents the data collected during the preliminary safety tests, and Section 4.2 presents the data 
collected during the pilot clinical trial. The data presented in this section has been processed following 
the methods discussed in Section 3.3. 
 
4.1. Preliminary Safety Tests 
As was discussed in Section 3.1, the outcomes of the preliminary safety tests were qualitative, and 
little quantifiable data was recorded. The following observations were made regarding the safe 
function of the device: 
 The safety buttons operated as intended – the device movement was halted when either of the 
buttons was released (see Section 2.2.3). 
 The limit switches were effective in limiting the range of motion to between +70° and -35° 
(see Section 2.2.3 and Section 2.1). 
 The EMG signal acquisition system operated as intended, and the device responded to 
participant EMG appropriately (see Section 2.3). 
Despite the main outcomes of the preliminary safety tests being qualitative, data on the times to 
complete the repetitions of the tests was extracted when the videos of the tests were reviewed. As was 
stated in Section 3.1, the potential to develop the device as an EMG-controlled active therapy tool 
exists, but is beyond the scope of this research. Data on the times to complete various tasks when 
using the EMG control mode may prompt further development in this regard. Times to complete 
repetitions varied as participants „learned‟ which muscle activation was related to each device joint 
movement (see Figure 4.1 to Figure 4.3).  






Figure 4.1 Times to complete repetitions during the first test in the preliminary safety 
test – five repetitions of finger flexion and extension performed by 15 
participants with no history of hypertonia (see Figure 3.2).  
 
 
Figure 4.2 Times to complete repetitions during the second test in the preliminary 
safety test – five repetitions of wrist flexion and extension performed by 15 
















































































Figure 4.3 Times to complete repetitions during the third test in the preliminary safety 
test – five repetitions of simultaneous wrist and finger flexion and extension 
performed by 15 participants with no history of hypertonia (see Figure 3.2). 
 
4.2. Pilot Clinical Trial 
4.2.1. Processed Data 
Figure 4.4, to Figure 4.9 show the plots of the force (and EMG data if available) that was collected 
during the tests. The force data was processed in the method described in Section 3.3.2. The EMG 










































Participant A – Average MAS score: 2.17 
Force Recordings  
 
Figure 4.4 Wrist and finger force recordings for Participant A during passive wrist and 
finger manipulation. Indicated are the different phases of device joint 
movement. From starting position (wrist and fingers at 0°): (i) Flexing 
fingers from 0° to +90°, (ii) extending fingers from +90° to 0°, (iii) flexing 
finger joint from 0° to +45°, (iv) flexing wrist from 0° to +70°, (v) extending 
wrist joint from +70° to -35°, (vi) flexing wrist from -35° to 0°, (vii) extend 
fingers from +45° to 0° (see Figure 3.6). The white areas between regions i – 
vii represent pauses in device motion. 
 




Participant B – Average MAS score: 2.67 
Force Recordings  
 
Figure 4.5 Wrist and finger force recordings for Participant B during passive wrist and 
finger manipulation. Indicated are the different phases of device joint 
movement. From starting position (wrist and fingers at 0°): (i) Flexing 
fingers from 0° to +90°, (ii) extending fingers from +90° to 0°, (iii) flexing 
finger joint from 0° to +45°, (iv) flexing wrist from 0° to +70°, (v) extending 
wrist joint from +70° to -35°, (vi) flexing wrist from -35° to 0°, (vii) extend 
fingers from +45° to 0° (see Figure 3.6). The white areas between regions i – 
vii represent pauses in device motion. 
 
i ii iii iv v vi vii 
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Participant C – Average MAS score: 2.67 





Figure 4.6 Flexor carpi radialis muscle EMG recordings (top) and wrist and finger force 
recordings (bottom) for Participant C during passive wrist and finger 
manipulation. Indicated are the different phases of device joint movement. 
From starting position (wrist and fingers at 0°): (i) Flexing fingers from 0° to 
+70°, (ii) extending fingers from +90° to 0°, (iii) flexing finger joint from 0° 
to +45°, (iv) flexing wrist from 0° to +70°, (v) extending wrist joint from 
+70° to -35°, (vi) flexing wrist from -35° to 0°, (vii) extend fingers from 
+45° to 0° (see Figure 3.6). The white areas between regions i – vii represent 
pauses in device motion. 
 
i ii iii iv v vi vii 
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Participant D – Average MAS score: 1.83 
EMG Recordings for Flexor Carpi Radialis 
 
 
Force Recordings  
 
Figure 4.7 Flexor carpi radialis muscle EMG recordings (top) and wrist and finger force 
recordings (bottom) for Participant D during passive wrist manipulation. 
Indicated are the different phases of device joint movement. From starting 
position (wrist and fingers at 0°): (i) Extend wrist joint from 0° to -35°, (ii) 
flex wrist joint from -35° to +70°, (iii) extend wrist joint from +70 to -35°, 
(iv) flex wrist from -35° to 0° (see Figure 3.7). The white areas between 
regions i – iv represent pauses in device motion. 
 
i ii iii iv 
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Participant E – Average MAS score: 2.33 





Figure 4.8 Flexor carpi radialis muscle EMG recordings (top) and wrist and finger 
force recordings (bottom) for Participant E during passive wrist 
manipulation. Indicated are the different phases of device joint 
movement. From starting position (wrist and fingers at 0°): (i) Extend 
wrist joint from 0° to -35°, (ii) flex wrist joint from -35° to +70°, (iii) 
extend wrist joint from +70 to -35°, (iv) flex wrist from -35° to 0° (see 
Figure 3.7). The white areas between regions i – vii represent pauses in 
device motion. 
 
i ii iii iv 
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Participant F – Average MAS score: 0 





Figure 4.9 Flexor carpi radialis muscle EMG recordings (top) and wrist and finger force 
recordings (bottom) for Participant F during passive wrist manipulation. 
Indicated are the different phases of device joint movement. From starting 
position (wrist and fingers at 0°): (i) Extend wrist joint from 0° to -35°, (ii) 
flex wrist joint from -35° to +70°, (iii) extend wrist joint from +70 to -35°, 
(iv) flex wrist from -35° to 0 (see Figure 3.7). The white areas between 
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Table 4.1 contains the data extracted from during the pilot trial. Of interest was the peak positive force 
as measured by the wrist and finger force transducers, occurring during extension of the wrist joint 
(i.e. phase „v‟ for Participants A, B and C, and then phase „vii‟ for Participants D, E and F). This 
occurs in the segment labelled „vi‟ for Figure 4.4 to Figure 4.6, and in the segment labelled „iii‟ for 
Figure 4.7 to Figure 4.9. This information was used with Equation 3.6 from Section 3.4 to estimate 
the tension in the wrist flexor tendons. Equation 3.6 requires the peak resistive force measured during 
wrist extension, as well as the finger force measured at the time that the peak wrist force occurred. 
Note that the tensions in the wrist flexor tendons are generally higher than the peak measured forces. 
This is due to the relatively small moment arm that the tendons have at the wrist and finger joints 
when compared with those of the measured forces. 
Table 4.1 also includes the MAS assessment scores as performed by the clinicians. Due to the testing 
being conducted at various institutions and at various times, the MAS assessments were not all 
conducted by the same clinicians in each case. MAS scores of „1+‟ were assigned the value of 1.5 
when calculating the average MAS score for each participant.  
Figure 4.10 graphically represents the MAS scores for all participants, illustrating the variability in 
scores between raters. 
 
Figure 4.10 Graphical representation of MAS scores for participants, illustrating the 
















































































































































o increase in m
uscle tone. 
D
istinct increase in m
uscle tone, but 
affected lim
b still easily m
oved. 




resistance through range of m
otion. 
C














istinct increase in m
uscle tone, but 
affected lim
b still easily m
oved. 
G





4.2.2. Statistical Analysis 
The following section describes the statistical outcomes of the study. The statistical methods were 
developed with assistance from Henri Carrara, a consulting statistician from the University Of Cape 
Town‟s Health Sciences faculty.  
Since the MAS scores are not normally distributed, the Spearman‟s Rank Correlation Coefficient was 
used to determine the agreement between the MAS scores and each of the two datasets1. These are 
namely: 
1. Correlation between the average MAS assessments for each participant and the peak force 
measured at the wrist. 
2. Correlation between the average MAS assessments for each participant and the estimated 
wrist flexor tension, as calculated with Equation 3.6. 
The data for these comparisons can be found in Table 4.1. The correlation coefficients were calculated 
based on the definition of the Spearman Rank Correlation Coefficient: 
  
∑(    ̅)(    ̅)
√∑(    ̅)
 ∑(    ̅)
 
 
In this definition, x and y represent the ranks of the two set of variables (rather than the actual variable 
values), and  ̅ and  ̅ represent their respective rank means. The Spearman‟s Rank Correlation 
Coefficient assesses how well the relationship between two variables can be described using a 
monotonic function. This is in contrast to the Pearson Product Moment Correlation Coefficient, which 
gives a perfect value when the relationship between the variables is linear, rather than monotonic. 
                                                     
1 A commonly used method for measuring the agreement between two clinical measures is a 
Difference plot (Bland and Altman, 1986). Such a plot quantifies the agreement (rather than 
correlation) between two clinical measures. Measures that show a high degree of agreement can 
be used interchangeably in the field (for example, two methods of measuring blood pressure). In 
the case of this research, the data being compared (forces and MAS scores) cannot be used 
interchangeably, and so the Difference plot is not applicable. If a repeatability study is performed, 
however, consecutive assessments made with the same participant can be compared for agreement 




For both of the correlation analyses performed, the correlation coefficient   was shown to be 0.81. 
Due to the nature of the Spearman Rank Correlation Coefficient using ranks rather than the actual 
values of the variables, the correlation coefficients for the two comparisons were identical. That is to 
say, even though the variables varied in relation to each other, their ranks within their respective 
datasets were the same, and as such the correlation coefficients were identical too.  
For the purposes of determining statistical significance, the Student‟s t value and corresponding p 
value were calculated. Similarly, the t and p values calculated were identical for the two correlations 
analysed. They were as follows: 
 t = 2.78 
 p = 0.0498 
The p value is below 0.05, indicating statistical significance.  
As was stated in Section 4.2.1, one of the MAS assessments for Participant E contradicted other 
observations (see table 4.1). One rater assigned a MAS score of 4, which is intended to indicate 
rigidity in both flexion and extension (see Table 1.2). Both other raters scored the participant as „1+”, 
indicating a slight catch followed by a minimal resistance across the range of motion. It should be 
noted that this participant‟s peak wrist force during wrist extension was the second lowest observed, 
second only to the healthy participant (see Table 4.1), and the EMG recording showed little activity in 
the flexor carpi radialis muscle during the test (see Figure 4.8).  
To augment the statistical analysis, the correlations were recalculated with the anomalous MAS 
assessment for Participant E omitted. The new average MAS score, calculated from the remaining two 
raters‟ assessments, was 1.5. For both of the correlation analyses that were recalculated, the 
correlation coefficient   was shown to be 0.99. As with the original correlations, the ranks for each 
variable in the calculation, and thus the correlation coefficients themselves, were identical. The 
corresponding t and p values were as follows: 
 t = 11.66 
 p = 0.0003 
The p value is below 0.05, again indicating statistical significance. The results of the analysis are 
summarised in Table 4.2 
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Table 4.2 Summary of the results of the statistical analysis 
 
Peak wrist force 
[N] 




with average MAS scores 
(primary result) 
0.81 0.81 
t-value 2.78 2.78 
p-value 0.048 0.048 
Spearman‟s Rank 
Correlation Coefficient 
with average MAS scores, 





















This section contains an analysis of the design, experimental methodology and results. It will begin 
with the preliminary safety tests, and proceeding to the pilot clinical trial. Lastly, recommendations 
for future work will be presented. 
 
5.1. Preliminary Safety Tests 
As was stated in Section 4.1, all safety features operated as intended. The aim of the preliminary 
safety tests was achieved: to demonstrate that the device is safe and functions as intended (see 
Objective 1 in Section 1.3). In addition to this, various other observations were made about the 
functioning of the device. 
One such observation was that there was a clear trend towards faster times to complete tests, as is 
illustrated in Figures 4.1 to 4.3. Participants quickly learned to control device joint movements, even 
in this short exposure (performing a total of only 15 repetitions of various given tasks). The fact that 
participants had initial difficulty in controlling the device, however, is an indication that the devices 
interpretation of participant gestures may not be optimum. In the ideal case, this gesture recognition 
would be seamless, and the device would recognise any wrist flexion, not just flexion performed in a 
particular way. For instance, one participant reported that trying to move his “thumb towards [his] 
elbow” helped achieve the task of device wrist joint flexion better than simply flexing his wrist. This 
action forces a stronger activation of the flexor carpi radialis muscle, and as such produces a stronger 
measurable EMG signal.  
Some participants reported difficulty isolating activation of one device joint from the other. For 
example, in trying to perform tasks of device finger joint flexion, some participants accidentally 
activated device wrist joint flexion too. This may indicate EMG cross talk between two channels, 
since the wrist and finger muscles lie in close proximity to one another. It may also be due to co-
activation of these muscle groups, since performing finger flexion usually necessitates stabilizing of 
the wrist joint which elicits EMG from the flexor carpi radialis muscle. 
The lack of a dedicated threshold adjustment for each EMG channel impeded performance in this 
regard. One threshold was shared between the wrist flexor and extensor channels, and another 
between the finger flexor and extensor channels. This arrangement was implemented due to 
microcontroller limitations. EMG signal strength, however, was affected by relative anatomical size 
and position of the target muscles. A common EMG threshold was often a compromise in 
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effectiveness for each channel. The inclusion of a dedicated EMG threshold for each channel is 
recommended for future work (discussed further in Section 5.3). 
Overall, the preliminary safety tests indicated that no safety risks were present and that the device 
functioned as intended. While some design modifications were implemented before the pilot trial (see 
Section 3.1.3), these were not motivated by safety concerns but rather by improved device 
functionality and noise reduction. Once these modifications were completed, the pilot trial could 
proceed. 
 
5.2. Pilot Clinical Trial 
5.2.1. Test Count and Statistical Analysis of the Results: 
The tests show strong correlations between resistive force and MAS scoresm, which is to be expected. 
Furthermore, this is in agreement with Lindberg et al. (2011), who reported that their study of the 
Neuroflexor device showed a “strong correlation” between resistive force and MAS (r>0.6, P<0.001). 
As Damiano et al. (2002) point out, isokinetic measurements and MAS scores both measure resistance 
to passive stretch, so it is logical to assume that they would be correlated. They also found strong 
correlations between these two measures. However, the results of the pilot trial (Section 4.2.2) suggest 
that there is no increase in the accuracy of wrist tone assessments made using estimated wrist flexor 
tension as opposed to peak force applied at the wrist. This is despite the moment arm that the finger 
flexor muscles may have at the wrist joint. This suggests that the effect that the finger flexors have at 
the wrist is negligible when compared to the wrist flexors. Certain factors relating to the experimental 
protocol and statistical analysis should be considered, however.  
Testing was terminated after 6 participants due to a lack of volunteers that met the inclusion criteria 
for the study. Volunteers for the pilot trial were sought from amongst the in- and out-patients at three 
care facilities in Cape Town: Groote Schuur Hospital, Life Vincent Pallotti Hospital and the Western 
Cape Rehabilitation Centre (see Appendix G for documentation regarding clearance to conduct 
research at these facilities). Suitable volunteers were successfully recruited from only the first two of 
these facilities. Willing volunteers were often available, but most did not meet the inclusion criteria of 
having comfortable (i.e. pain free) range of motion up to 35° in extension. This was despite the range 
of motion criteria for the study being the same as that required by similar research in literature, such 
as studies with the NeuroFlexor device by Lindberg et al. (2011). The work by Pizzi et al. (2005) also 
suggested that those with mild to moderate hypertonia in the wrist would have sufficient range of 
motion to participate (see Figure 1.4). It was suspected that individuals with larger ranges of motion 
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and with less pain are likely to be discharged earlier and are less likely to be encountered at a care 
facility. It is possible that the volunteers were recruited for this research from a population with 
anomalously low ranges of motion relative to their MAS scores. 
Despite statistical significance, the low test count may have influenced the statistical analysis. 
Consider also that the Spearman‟s Rank Correlation Coefficient correlates the ranks of the variables 
in two datasets, rather than the variables themselves. Due to the relatively small test count, the ranks 
of the two values being compared in this research (wrist force and the wrist flexor tendon tension) are 
likely to be similar, even if their actual values relate to the MAS score differently. As an illustrative 
example, consider the hypothetical variables Y1 and Y2 that increase linearly and exponentially with 
variable X respectively (see Figure 5.1 and Table 5.1). Despite having different mathematical 
relationships with X, the variables Y1 and Y2 have identical ranks within each paired dataset. Each 
would produce perfect (and identical) Spearman‟s Rank Correlation Coefficients with variable X, 
despite not being identical functions of X. Similarly, the peak wrist forces and estimated wrist 
tensions measured in the trial could be expected to produce identical correlation coefficients when 
compared to the MAS scores. With a higher test count, however, identical ranking is unlikely and 
differences in correlation would become apparent.  
Another point for consideration is the use of average MAS scores as a gold standard. The MAS score 
has been criticized for its unreliability (see section 1.1.5). Even the average of three raters‟ MAS 
scores may not be reliable enough to serve as a proxy for hypertonia severity. Achieving statistical 
significance suggests that that the sample size (n=6) is large enough that the probability of the 
observed correlations being due to anomalous recordings is small (less than 5%). The effect of the 
unreliable MAS score, however, is illustrated by the marked difference that a single score had on the 
outcome. When a score from one rater was omitted for only one participant (see Section 4.2.2), the 
overall correlation coefficients increased from 0.81 to 0.99 – an increase of 22.2%. For experimental 
robustness, the outcome should not be so reliant on individual observations so much as overall trends. 
Despite the results indicating statistical significance at this sample size, experimental robustness could 
be improved by increasing the test count or by replacing the MAS score as the gold standard for 
analysis. 
Table 5.1 Hypothetical variable X, Y1 and Y2, illustrating that the ranks of the variables are identical 
X Y1 Y2 
Rank of Y1 
(lowest to 
highest) 
Rank of Y2 
(lowest to 
highest) 
1 1 1 1 1 





Figure 5.1 Hypothetical variables Y1 and Y2 which vary linearly and exponentially 
with X respectively 
 
5.2.2. Force Recordings 
The estimate of the expected peak force of 30 N (with a safety factor) was appropriate. The highest 
recorded force was from Participant A, who exerted a peak of 33.32 N in extension (i.e. a negative 
recorded force) to the finger joint transducer. Participant A had an average MAS score of 2.17. The 
values recorded were in agreement with the data presented by Lindberg et al. (2011). In their study, 
the highest resistive force recorded was approximately 37 N from a participant with a wrist MAS of 3.  
In general, the observations follow intuition. Participants with a higher average MAS score generally 
also exhibit more fluctuant force activity. This is evident when one compares Figure 4.9 to Figure 4.5 
or Figure 4.6 (the lowest and highest MAS scoring participants). The expectation was that clear force 
peaks would be observed during wrist extension, and that these peaks would be more pronounced in 
those with higher MAS scores. This is observed most clearly in Participant C and Participant D, for 
whom recordings show clear force activity during wrist extension (see Figure 4.6 and Figure 4.7). 
Note that the peak force observed by participant C occurs exactly as peak wrist extension occurs, and 
subsides partially during the subsequent pause. This is consistent with the velocity dependent 
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Furthermore, periods of EMG activity can clearly be seen to coincide with rises in recorded force. 
This indicates that these forces are at least partially neural in origin (for example, see Figure 4.6). 
Note that almost no wrist flexor EMG activity or wrist flexor force activity was observed for 
Participant F (Figure 4.9), who had a MAS score of 0. Some finger force activity was observed, 
although without finger flexor and/or extensor EMG recordings one cannot say definitively whether 
the activity observed is neural in origin. Since this participant had no history of hypertonia, it is 
probable that this force was due to viscoelastic effects. 
The reduction of motor speed that was implemented following testing with Participant C (see Section 
3.1.3) is a possible factor that must be considered. The modifications were necessary to avoid 
unnecessary discomfort to participants. They may, however, have influenced the results since some 
features of UMNS - such as spasticity - are velocity dependent. This variation in motor speed was 
therefore not ideal. It may be reasonable to expect that tests with slowed motors (Participant D, E and 
F) would result in smaller peak wrist and finger forces. While this is indeed reflected in Table 4.1, it 
should also be noted that these participants also had the lowest average MAS scores. While is it is 
uncertain whether this velocity dependence is so strong that results would be affected considerably, 
this is one of the factors preventing definitive conclusions from being drawn. Due to the low test 
count, data could not be pooled by velocity for separate analysis. See Section 5.2.1 for a discussion of 
the test count. As such, the results from this study represent preliminary findings, and the various 
recommendations for future work in Section 5.3 include maintaining of consistent velocities during 
tests as well as pooling of tests by velocity. Lastly, the presence of artefact was noted in the force 
readings. This is especially pronounced in results from tests with the slower motors installed 
(Participants D, E and F - see Figures 4.7 to Figure 4.9). The artefact occurs at the beginning of each 
phase of movement and is visible as a strong negative dip in the recordings. This is a result of EMI 
from the motors that occurs on start up. It is apparent that the slower motors radiate substantially 
higher levels of EMI. This duration of the effect was prolonged by pulse width modulation 
implemented at the beginning of each movement as a „soft start‟ to prevent violent jerking of the 
device joints. Note that none of the peak wrist or finger forces that were extracted from the data 
(Table 4.1) occurred during these periods. It is possible, however, that the artefact was masking forces 
that could otherwise be observed. 
EMI from the motors introduced noise into the strain gauge bridges and the cables that carry signals to 
the force amplifiers. While shielding mitigated this effect, it did not eliminate it. The signals in these 
cables had a very low signal-to-noise ratio, and were especially susceptible to EMI. This noise could 
be reduced by using motors that create lower levels of EMI (e.g. stepper motors), and by relocating 
them such that they are not in such close proximity to the sensitive force transducers. This is 




5.2.3. Biomechanical Model 
The outcomes of the biomechanical model follow intuition. That is to say, the estimated wrist flexor 
tensions have approximate magnitudes that are of the expected order. Consider that the highest 
tension in the wrist flexors estimated by the model was 84.2 N. If we assume that this load was shared 
evenly between the two prime wrist flexors (flexor carpi radialis and flexor carpi ulnaris), and that 
each tendon had a round cross section of 5mm diameter, the tension in each would be 2.14 MPa. For 
comparison, the ultimate tensile strength of the flexor carpi radialis muscle has been shown to be at 
least 51.6 MPa (Loren and Lieber, 1995). The highest tension estimated by the model represents 5.1% 
of the load capability of the tendon, which follows intuition and lends credence to the model. 
The assumptions on which the model relies should be considered. These are namely: 
1. The assumption of a system in a state of static equilibrium (i.e. inertial effects were small). 
2. Simplification of joint morphology: in the model, joints are treated as simple hinges when in 
reality the centre of joint rotation (and tendon moment arms) vary with joint angle. 
3. The assumption that all participants had similar joint morphologies. Common values for 
finger and wrist flexor moment arms were adopted for all participants (i.e. the values for 
dtendon,finger and dtendon,wrist). 
 The first two assumptions are unlikely to appreciably affect the model; the device acceleration was 
slow enough that inertial effects could be ignored, and the treatment of the joint as a simple hinge was 
deemed acceptable. A possible improvement, however, might be to compensate for biomechanical 
effect of different hand sizes. Measurements of participants‟ hands could be used to scale the assumed 
tendon moment arms, and provide more accurate estimates. This is included in recommendation for 
future work. 
 
5.2.4. EMG and Neural vs. Non-neural Hypertonia 
A rise in wrist flexor EMG was observed to be accompanied by a positive wrist flexor force in almost 
all instances where EMG was collected. The exception was with Participant F (see Figure 4.9) - no 
rise in wrist force was observed to coincide with the observed EMG activity at the end of phase i. 
Note that Participant F had no history of hypertonia. In healthy individuals, EMG activity is a normal 
response only to high velocity stretch (i.e. the knee-jerk reflex). It should not be observed in passive 
stretch of healthy muscle. The observed EMG may be a result of the participant stabilizing their wrist 
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(a voluntary action). Such wrist flexor activity would result in no net wrist force, since it would be 
opposed by wrist extensors. 
There is, however, a rise in Participant F‟s finger force at the end of phase i, which is again observed 
to rise and peak towards the end of phase iii. The rise in finger force seen at these points might be 
attributable to viscoelastic joint/muscle properties. Without finger flexor EMG, however, the 
possibility of the force being neural in origin cannot be ruled out. Regardless, these increases in finger 
force did not affect the results: the biomechanical model required the magnitude of the finger force at 
the time when the peak wrist force during wrist extension occurs. For Participant F, this occurs before 
the rise in finger extension is observed.  
For Participant E (see Figure 4.8), a low level of EMG activity was present even before the start of 
phase i. This activity can be seen to subside slightly at the end of phase ii and resume during phase iii. 
That is to say, the EMG subsided when the wrist joint was flexed. A negative force (i.e. a force in the 
extension direction) was observed to occur simultaneously. This may be explained by the process by 
which the force readings were zeroed. Recall that in Section 3.3.2, it was stated that the baseline for 
force recording was obtained by averaging the first 1000ms of data in each recording. The recordings 
only began, however, once the participant had already been strapped into the device. If a force was 
applied to the device during the 1000ms interval, the baseline would not represent a zero value. In 
addition, flexion of the joint might relieve tension in the wrist and finger flexors. Hypertonia is a 
stretch response, so the relief in tension would result in an observed reduction in both EMG and force. 
It is recommended that protocols for future research be constructed such that force baseline recordings 
are captured during a time when the participant is not secured into the device (see Section 5.3). 
 
5.2.5. MAS Scores 
There is little agreement between the three raters regarding the MAS scores (see Table 4.1 and Figure 
4.10). In no instance did all three raters agree on a single score for a participant. The average standard 
deviation of MAS scores was 0.73, which represents almost a full step on the 5-point ordinal scale. 
This poor interrater MAS agreement is corroborated by other analyses in literatature (e.g. (Blackburn 
et al., 2002; Ansari et al., 2006; Alibiglou et al., 2008; Mutlu et al., 2008). The study by Mutlu et al 
(2008), for instance, states that MAS scores are “not very reliable and assessments of spasticity using 
these scales should be therefore interpreted with great caution”. This lack of agreement from raters 
corroborates research that suggests that the MAS score is unreliable. It underscores the need for an 
objective measure of muscle tone.  
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The high variability of MAS scores also may have had an effect on the results of this study. This is 
apparent in Section 4.2.2 when the correlation coefficients were recalculated omitting an anomalous 
MAS score. The results were dramatic – the correlation coefficient increased by 22% (discussed in 
Section 5.2.1). The fact that a single MAS score had such a pronounced effect indicates a potential 
lack of robustness in the experimental protocol. It is possible that even the average of three 
independent MAS scores is not a reliable proxy for the severity of hypertonia, and does not serve as a 
reliable gold standard for research. Potential solutions to this may include replacing the MAS score 
with another measure of muscle activity – such as EMG activity – or to increase the test count such 
that individual scores have less of an effect on research outcomes. 
Note that the tests were performed at various facilities, and at various times. The same raters were not 
available to perform assessments for all participants. Individual MAS assessments cannot be 
compared across participants to identify trends. That is to say, one cannot determine from the results 
of this study if one rater consistently scores participants as having higher or lower muscle tone. 
It should also be noted that there appears to be no standardised procedure for the method of 
performing the MAS assessments. In the publication where the MAS score was first described 
(Bohannon and Smith, 1987), assessments of elbow flexor tone were performed. There was no 
description of a standard method for wrist assessment. For example, some assessors may extend the 
wrist joint while holding the finger joint in a fixed angle. Others may allow the finger joint to move 
freely. The effect of this is that some clinicians may be allowing finger flexor hypertonia to influence 
wrist joint assessments, while others may not. While the results of this research indicate that there is 
no improvement in accuracy when comparing biomechanical results to the average MAS score, this 
may not be true of individual raters (see Section 5.3.3). Investigation into the development of a 
standardized method for MAS assessment is recommended for future work. 
 
5.3.6. Ergonomics 
Manipulation of the finger joint was abandoned from the protocol due to design issues with finger 
ergonomics (see Section 3.2.2). Movement of the device finger joint often resulted in the participants‟ 
fingers slipping out of place. This is a result of the lack of adjustability for various hand sizes, and 
was more likely to occur with participants with smaller hands.  
The inclusion of finger manipulation would have allowed further analysis of data in this study. Finger 
flexor tone could have been assessed in the same way as was performed with the wrist. Such data 
could have been used to further confirm methods ability to accurately assess hypertonia. Such data 
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would also have helped provided a more complete clinical picture for each participant. This issue 
should be addressed in future design revisions.  
Note also that the current ergonomic design made it difficult to position the hands of participants with 
extreme weakness. Specifically, participants were often unable to hold their fingers rigid for insertion 
into the device components. While this lead to difficulty during setup, it did not impede testing or 
affect the results. This should also be a factor for consideration for future design revisions (see 
Section 5.3).  
 
5.3. Recommendations for Future Work 
The results indicate no improvement in assessment accuracy when using the device and the 
biomechanical model (see Section 4.2.1). However, certain factors could have affected the results (see 
Section 5.2). This section provides a discussion of recommendations for future work based on these 
points. 
5.3.1. Device Design Modifications 
The recommended changes are intended to improve recording quality (e.g. reduction of noise) and 
ergonomics. They are as follows: 
 Replacement of brushed DC electric motors with a different actuation method. It is 
recommended that stepper motors be considered. Various advantages would be offered by 
such a modification: 
o Noise due to EMI in the force recordings would be reduced.  
o Velocity management would be improved, allowing more uniformity across 
participants. 
o Joint position could be digitally monitored, and setting of limits of the range of 
motion could be applied and adjusted in software. Hardware implementation (limit 
switches) do not offer such adjustability. Recall that range of motion was the leading 
factor in exclusion of volunteers (see Section 5.2.1). Adjustability would allow 
testing with a greater number of participants.  
 Removal of actuators away from the force transducers. This would further reduce noise in the 
force recordings due to EMI. Furthermore, relocation of the actuators would minimize 
unnecessary weight being shifted during device joint manipulation – a factor which 
contributed to force drift (see Section 3.3.2).  
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 Improvement of ergonomics. Redesign of the ergonomic components is recommended. It is 
recommended to use detachable components that may easily be secured onto the participant‟s 
hand without complication. These components could then be easily attached to the structure 
of the device. The system should also be adjustable such that various hand sizes can be 
accommodated.  
 Inclusion of dedicated EMG activation threshold adjustment knobs. Each EMG channel 
should have its own dedicated EMG activation threshold adjustment. 
 
5.3.2. Experimental Protocol  
The following points should be considered for future revisions of the experimental protocol: 
 Uniform velocity for all participants. It was unavoidable in the experimental protocol that the 
joint velocity of the device be altered after testing with Participant C (see Section 3.1.3). This 
was not ideal, since some features of UMNS are a velocity dependent. It is recommended that 
future experimental protocols be conducted at uniform velocities across participants. 
Furthermore, for each participant tests should be repeated at various velocities – using the 
same velocities across participants – such that resistance profiles at each velocity can be 
compared. 
 Use multiple measures to validate readings. Since the reliability of the MAS score has been 
shown to be questionable (see Section 1.1.5), it is not suitable as a validation technique. 
Alternative validations should be sought. Possible measures include EMG power, the use of 
varying velocities (to test velocity dependence), and more reliable scales such as the Tone 
Assessment Scale. Ideally, a combination of validations should be used. 
 EMG for both wrist and finger flexors and extensors should be recorded. The results depict 
relatively large forces in the extension direction (see Section 4.2.1). In tests that include EMG 
recordings, only wrist flexor activity was recorded to reduce discomfort associated with skin 
preparation. Without EMG recordings of the wrist extensor muscles as well as finger flexors 
and extensors, the distinction between neural and viscoelastic force cannot be made. 
 Separate recording of the force transducer baseline. A recording for the baseline of the force 
transducers (later used to zero the recordings) should be performed before the participant is 




5.3.3. Other Recommendations 
Although results suggest no effect of finger flexor torque at the wrist when forces or tensions are 
correlated with the average MAS score, this may not necessarily be the case for individual MAS score 
correlations. It was not possible to compute individual MAS score correlations in this study because 
the individual MAS assessments were not performed by the same raters across all participants. 
It is hypothesised that individual MAS scores correlated with wrist flexor tension would vary 
significantly between raters. If so, that would support not only the use of objective quantitative 
devices but also more standardization of the MAS method for the wrist joint (see Section 5.2.5). 
 
5.3.4. Opportunities for Further Research and Development: 
In addition to the objectives presented in Section 1.3, other research and development aims could be 
perused. Examples of these include, but are not limited to, the following: 
 Once developed further, the device should be investigated for repeatability. One possible 
approach is to perform consecutive recordings using the device, and to analyse the results 
with a difference plot (Bland and Altman, 1986) 
 The device could be used to analyse the effect of various available treatment paradigms being 
implemented in the field. Muscle tone of individuals could be assessed as they undergo 
various interventions to determine the relative effectiveness of each. This includes physical 
therapy as well as pharmacological interventions. 
 The device could be developed to include functionality as a task-oriented therapy aide for 
hemiparetic patients. The results of the preliminary safety test confirm that the device can be 
controlled using EMG as an input. Development of this system may allow hemiparetic 
participants to undergo task-oriented therapy with assistance from the device, which has been 












The research presented in this thesis set out to prove the hypothesis that a robotic device for wrist 
flexor hypertonia that compensates for the effect of finger flexor torque at the wrist joint can provide 
more accurate wrist flexor muscle tone assessments than one that does not. The first objective was to 
design, construct and test a patient-safe device for the evaluation of wrist flexor muscle tone. The 
second objective was to compare the MAS score for volunteers with hand/wrist hypertonia against 
two methods of evaluation with the device - peak wrist force during passive wrist extension and 
estimated peak wrist flexor tendon tension using a biomechanical model.  
The first objective was achieved, and a device capable of measuring wrist and finger force during 
joint manipulation was constructed, although opportunity for design improvement exists. Noise in the 
force recordings could be mitigated by implementation of a different actuation method. Similarly, 
design alterations such as adjustable range of motion would allow for more extensive testing – since 
there was a lack of volunteers that met the range of motion inclusion criteria. 
The second objective showed that the methods of tone assessment with the device, using peak wrist 
force and peak wrist flexor tendon tension, both correlated strongly – and identically – to the MAS 
assessments. These findings suggest that the either method may provide acceptably accurate 
assessments of muscle tone. Furthermore, the results suggest that the influence of the finger flexor 
hypertonia on wrist joint torque is small relative to that from the wrist flexors themselves. Factors that 
should be considered, however, include the fact that the MAS score itself is unreliable, and that even 
the average of three MAS scores for each participant may not be a suitable proxy for hypertonia 
severity. Similarly, elements of the experimental protocol may have influenced the results (most 
notably, the non-uniform joint velocities for various tests). While these factors prevent definitive 
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Appendix A – Device Design and Manufacture 
A.1. Device Structure 
The device consisted of various interacting elements. These included: 
 Main structural components – Plastic or aluminium. These connect, locate and support the 
motors and other components and provide a framework and base upon which to stand 
 Force sensing elements – Aluminium. Fitted with strain gauges for the purposes of measuring 
load applied to them (i.e. force transducers). 
 Interface elements – Aluminium. These directly interface with the participant, lined with 
foam rubber for comfort 
 
Elements are illustrated in Figure A.1, which illustrates a partially exploded view of the device.  
 
Figure A.1 Partially exploded view of a CAD model of the device, illustrating 
interactions between the main structural elements (A), force sensing 
elements (B), and interface elements (C). 
 
A.2. Ergonomic Elements 





Figure A.2 Photograph showing the device with a participant‟s hand secured 
(Reproduced from Figure 2.3) 
 
Points for consideration were: 
 The two degrees of freedom (rotation at the wrist and MCP joints) necessitated independently 
moving sets of interface elements. 
 Force was transmitted from the interface elements to the force transducer components by 
means of four M4 bolts on each assembly (see Figure A.3). Spacer nuts were included to 
ensure no unintended contact between these components.  
 The interface elements were modularly separate from the force component elements. This 
allowed for potential changes to be more easily implemented. This prevented the need for 
reapplication of the strain gauges following an interface element design revision.  
 All the interface components were fabricated using folded 2 mm sheet aluminium (grade 
1050-H14).  
 All surfaces on the device that interface with the participant were coated with foam rubber.  
 Adjustments for participant hand size were not included in this prototype design. Such 
adjustments are recommended to be added to future versions of the device (see Section 5.3.1). 
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A.3. Design of the Force Transducer Elements 
Two identical force transducer elements were required. One measured the force applied to the finger 
interface elements and another to the wrist elements (see Figure A.2). These consisted of folded 
aluminium components, referred to as force sensing elements, with strain gauges attached. 
All other elements could be designed with large safety factors to ensure that they would not fail. The 
force transducer elements, however, were required to have thin gauge sections to allow for 
measurable strains of relatively small forces.  These elements were designed in conjunction with the 
corresponding strain gauge amplification circuitry (see Appendix B).  
The force sensing elements were made from 1050-H14 sheet aluminium. Calculations showed that 
2mm gauge sections were appropriate (see sections A.3.1 and A.3.2).  
 
Figure A.3 CAD model of a force sensing element indicating relevant design features 
 
Strain gauges mounted 
onto the front surface of 
the gauge section (also 
applied identically to the 
opposite back face, not 
visible in this image) 
Holes for location 
onto structural 
elements* 
Holes for locating 
fasteners (with spacers) 
for interface component. 
Force from the participant 
is transmitted axially 
through these bolts* 
* see Figure A.1 
Slots included due to early 
prototypes using Velcro 
straps. The slots were retained 
in case the Velcro straps 




The designs of the wrist and finger transducer elements were very similar (see Figure A.3). The 
design consisted of a flat piece of sheet metal, with folded tabs at the ends for location to the 
structural elements. The interface elements were attached using bolts and spacers nearer the middle. 
Strain gauges were attached at the centre, on the front and back surfaces of the gauge section. These 
were wired into a full bridge configuration such that the bending strain in the gauge section of the 
material was measured.  
 
A.3.1. Calculation of Force Sensing Element Material Thickness 
The initial estimate for the peak force from the participant would be up to 30 N, since participants for 
the study would have from mild to moderate hypertonia of the hand and/or wrist. Participants with 
more severe hypertonia were excluded from the study. The basic calculations presented here were 
confirmed with finite element modelling (see Section A.4) as well as empirical calibration (see 
Section A.3.2) 
The applied force through the four bolts could be represented in cross section by a pair of equal 15 N 
point forces. Since the body is assumed to be in static equilibrium, and due to symmetry, the values of 
the reaction forces are also 15 N each. The element could be modelled as a simple beam with applied 
forces from the interface element, and reaction forces from the structural elements. The shear force 
and bending moment distributions in the part could be derived from the free body diagram (see Figure 
A.4). 
The peak bending moment (occurring in the gauge section) was calculated to be 0.2625 N.m. This 
value was used in the flexure formula to calculate the bending stress in a beam at those points 
(Juvinall and Marshek, 2011): 
  
   
 
 
          (Equation A.1) 
„M‟ is the bending moment in the beam at the point of interest (in this case, the gauge section), „σ‟ is 
the bending stress at this point, „y‟ is the distance from the neutral axis and „I‟ is the second moment 
of area about the neutral axis. Equation A.1 shows that the stress is proportional to both the bending 
moment and the distance from the neutral axis. The material thickness, still to be determined, was 





Figure A.4 Free body diagram, shear force diagram and bending moment diagram of 
the force sensing element. Note that the maximum bending moment 
(located in the gauge section) is 0.2625 N.m. 
 
The second moment of area for a rectangular cross section could be expressed in terms of parameter h 
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(Equation A.2) 
Using the calculated maximum bending moment in the beam (see Figure A.4) and by substituting 
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(Equation A.3) 
If h was selected to be 2mm (an available standard thickness for 1050-H14 aluminium), then the stress 
in the beam at the gauge section (see Figure A.4) could be calculated as: 
  
      
      
 
         
(Equation A.4) 
The yield strength of 1050-H14 sheet aluminium is specified by manufacturers to be 103 MPa 
(“Matweb,” 2014). The safety factor was 10.5, which was more than sufficient. It was required, 
however, to confirm that the strain „ε‟ was high enough to allow measurement with sufficient 
resolution. 1050-H14 aluminium has a modulus of elasticity „E‟ of 69.0 GPa, so the strain could be 






       
        
 
          
(Equation A.5) 
The strain gauge amplification circuits had a transfer function relating strain to output voltage as 
follows (see Section B.4): 




Note that this was only valid while the bending stress due to loading was within the linear range (i.e. 
the material was still loaded within the elastic region). For these experiments, however, the maximum 
expected loading was below that required to induce any plastic strains, as evidenced by the large 
safety factor. At the expected maximum load, the measured voltage from the strain gauge amplifier 
circuit was calculated to be 276.0 mV. This range was large enough to be measured with sufficient 
resolution but not so large as to risk saturating the data logger. 1050-H14 sheet aluminium with 
thickness of 2mm was deemed appropriate. 
 
A.3.2. Force Transducer Calibration 
Many factors could have contributed to a deviation between real-world behaviour and the model used 
in section A.3.1. These include, but are not limited to: 
 Non-uniform application of force to the interface element 
 Stresses in the force sensing element due to other sources than the applied force, (e.g. 
fasteners used to locate the interface components or residual stresses from manufacturing 
procedures) 
 Uncertainty in the accuracy of components used in the amplifier electronics (e.g. from the 
exact value of the external resistor used to select the gain of the amplifier) 
 
As such, the system calibration was performed, empirically relating applied force and voltage output 
(see Figure A.5 for a sketch of the calibration setup). A simple system using a rope, pulley and 
weights was used to apply a known force to a harness attached to the interface element. The process 
was repeated in a similar fashion for flexion and extension of the finger and wrist force sensing 
elements.  
The step-by-step methodology for this calibration was as follows: 
1. The device finger and wrist joints were at 0° (i.e. aligned straight). 
2. The device was positioned appropriately and a harness attached such that the tension force 
applied through the rope was in the appropriate direction (i.e. it was required be normal to the 
surface on which the strain gauges were attached). 
3. The rope from the harness was run over the pulley (the cradle was not attached yet). 
4. The offset on the strain gauge amplifier electronics board was adjusted until the plot of the 
force reading in the PC-based GUI showed approximately 2V (mid-range in the 0 – 5V 





Figure A.5 Sketch of the calibration apparatus illustrating how a known force was 
applied to the interface element from weights via a rope over a pulley. 
 
5. The recording was initialized in the GUI. This was referred to as time t=0 seconds. 
6. No action was taken for 30 seconds, to establish a stable baseline reading. 
7. At t=+30s, the cradle (weighing 0.7 kg) was attached to the end of the rope. The cradle was 
pressed down gently then released. This created a “spike” in the readings which was helpful 
for data processing later to distinguish time steps. 
8. Again, no action was taken for 30 seconds for the reading to stabilize and to provide a time 
interval for calculation of an average value. 
9. At t=+60seconds, a weight was placed into the cradle, and again the cradle was briefly 
pressed down gently to create a spike in the readings. 
10. The total mass of the weights applied were recorded.  
11. Again, a 30 second pause was observed to allow readings to stabilize and to provide a time 
interval for acquisition of an average value. 
12. Steps 10, 11 and 12 were repeated until all weights had been applied (a total weight of 4.5 
kg). 
13. Using 30 second time steps in a similar fashion to the loading procedure, the weights were 
gradually removed until no weights remained. 
14. When no weights remained, a further 30 second pause was observed to obtain a closing 
baseline value. 
15. The recording was terminated. 
16. This process was repeated for finger flexion, finger extension, wrist flexion and wrist 
extension. 
 
Plots of the recorded calibration data for the wrists and fingers can be seen in Figure A.6. The data 




Figure A.6 Plots of raw data collected during calibration of the force measurement 
system. 
 
The calibration data was processed according to the following procedure, which was performed in 
Microsoft Excel 2010: 
1. The data was zeroed by subtracting the average value of the data collected during the first 25 
seconds of recording. 
2. The spikes in the force reading associated with a change in loading were identified. The 
recorded data was averaged over the time interval from 15 seconds to 25 seconds after each 
weight was applied (i.e. a 10 second interval). These averages were manually checked to 
ensure that the signal had in fact stabilised and that no unwanted disturbances were present 
(such as due to the table being bumped). For each weight step, the average recorded voltage 
was noted as well as the corresponding weight applied.  
3. The noted weights and corresponding voltages were plotted. A linear trend line was applied, 
which uses the least squares method. Since the data was zeroed before processing, the trend 
line was constrained to pass through the origin. The R2 value was also calculated (see Figure 
A.7 and Figure A.8) as a measure of the quality of the fit. Note that differences between the 
voltage outputs for loading and unloading curves were small. This indicated that hysteresis in 



























Figure A.7 Plots of processed calibration data for the finger force transducers, 
indicating the relationship correlation between applied force and voltage 
from the strain gauge circuitry. Shown on the graph are the equations of 
the linear trend lines for flexion and extension, and the R2 values to 
indicate the quality of the trend line fit. 
 
 
Figure A.8 Plots of processed calibration data for the wrist force transducer, 
indicating the relationship correlation between applied force and voltage 
from the strain gauge circuitry. Shown on the graph are the equations of 
the linear trend lines for flexion and extension, and the R2 values to 
indicate the quality of the trend line fit. 
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A.4. Finite Element Analysis of Selected Components 
 A simple finite element analysis (FEA) of the force sensing element components was performed to 
confirm design calculations. Furthermore, some certain structural components were modelled where 
safety was concerned (i.e. hyperextension blocks – see Section 2.2.3). This section details the process 
FEA analyses. 
The device was designed using the SolidWorks 2011 x64 edition computer aided design (CAD) 
package. The program included the Simulation add-on, which was used to implement the required 
FEA. As with all FEA models, parameters such as material properties, part fixtures/restraints and 
loading were modelled. Global and site-specific controls for mesh generation of a part were applied 
and were analysed to ensure that the mesh did not significantly affect the results of the analysis. Each 
part was modelled with three meshes with incrementing coarseness. The results from the three models 
were compared to each other to confirm reliability. 
There were three components that were modelled under expected loading: The finger force transducer 
sensing element as well as proximal and distal structural components. 
 
A.4.1. Finite Element Analysis of the Distal Force Sensing Element 
FEA was used to model the expected peak stress and strain in the distal force sensing element to 
ensure that they comply with the calculations in section A.3.1. Since the geometry and loading of the 
wrist and finger force sensing elements were similar, only one was modelled.  
The loading consisted of forces applied at the bolt holes where the interface element would be 
attached. The restraints were applied at the holes on the folded tabs where the component located onto 
the structural elements (see Figure A.10). Note that the slots were included as features of the design 
due to earlier versions including Velcro straps. The slots were retained in case these Velcro straps 
were once again required. 
The part was analysed with two loading configurations: with the force applied in the positive and 
negative directions. This was to check that the peak stresses would be of the same magnitude, but with 





Figure A.9 CAD model of a partially exploded assembly indicating components that 
were analysed using FEA models 
 
As was stated in Section A.3.1, an expected applied load of 30N from the participant was estimated. 
In the model, this load was transmitted to the force sensing elements via the bolts in the holes 
surrounding the strain gauges (see Figure A.10). The FEA model was constructed such that the 30N 
force applied by the participant would be distributed evenly throughout all four bolt holes (7.5N 
each). Fixed geometry restraints were applied on the holes on the top and bottom and bottom folded 
tabs of the force sensing elements, effectively locking the inner surfaces of these holes in space. 
The global element size of the primary model was set to 2mm. The part was also analysed with the 
element size setting set to 50% and 150% of the initial size (1mm and 3mm respectively). This was to 
confirm that the mesh selection had little effect on the outcomes of the model. Mesh controls were 
also applied such that the regions surrounding the slots and holes had a finer mesh, since stress 
concentrations effects near these areas were expected to cause steeper stress gradients. A finer mesh 
was required to accurately resolve the stress in these regions. Six models were created in total - two 
loading configurations (for positive and negative force directions) with three mesh coarseness settings 





Figure A.10 CAD model of a force sensing element, illustrating the loading and 
restraints applied in the FEA model 
 
The outcomes of the models showed that the peak stressed did not vary considerably between models. 
The stress distributions on the surface of the part for the various models are illustrated in Figure A.12 
to Figure A.17. The highest peak Von Mises stress observed was 24.11 MPa (see table A.1 and A.2), 
occurring in the 3mm element (secondary) models, identical for both force directions. The lowest 
peak stress was 23.68 MPa, again occurring identically in the secondary models (1mm element size in 
this case). The yield strength of 1050H14 sheet aluminium, as specified by manufacturers, is 103 
MPa. The lowest safety factor for all models was 4.27. Note that this safety factor is lower than that 
predicted by the calculation in Section A.3.1, since this model accounts for factors such as stress 
concentration effects at the slots. Despite being lower, this safety factor is still acceptable. 
 
Holes for location onto 
structural elements, the 
inside surfaces of 
which were defined as 
restraints in the FEA 
model* 
In the FEA models, 
positive and negative 
forces of 7.5N each were 
applied to each hole in 
the axial direction. In 
this image, positive 
forces are shown.* 




Figure A.11 CAD models of the force sensing element illustrating the meshes used in 
the FEA models: 2mm mesh used as the primary model (centre), and the 
1mm mesh (left) and 3mm mesh (right) used to confirm the results. 
 
The safety factor was not the only design consideration for this component: the strain in the location 
of the strain gauges was also important. The “probe” feature in the FEA software was used to obtain 
an estimate of the strain that the strain gauges would experience. Only the strain in the vertical 
direction was probed, rather than principle or effective strains, since the strain gauges were only 
sensitive in that direction. The average strains probed in the region of the front and back gauges (as 
well as other relevant numerical data) are presented in table A.1 and table A.2. 
Table A.1 Numerical results from FEA model of force sensing element with positive 
forces applied. Note that the stresses are identical but the direction of the 





























Secondary 1 0.5 23.68 -1.1% -107.0 93.9 
Primary 2 1 23.94 - -106.9 93.6 





Table A.2 Numerical results from FEA model of force sensing element with negative 
forces applied. Note that the stresses are identical but the direction of the 





























Secondary 1 0.5 23.68 -1.1% 107.0 -93.9 
Primary 2 1 23.94 - 106.9 -93.6 
Secondary 3 1.5 24.11 0.7% 106.2 -92.8 
 
 
Figure A.12 FEA model of the force sensing element with negative forces applied and 
with a mesh element size of 2mm. The image indicates the Von Mises 
stress distribution results of the FEA model (with exaggerated 
deformation). The legend provides Von Mises stress results measured in 
N.m-2 (i.e. pascals). This was the primary model, validated by the 







Figure A.13 FEA model of the force sensing element with negative forces applied and 
with a mesh element size of 1mm. The image indicates the Von Mises 
stress distribution results of the FEA model (with exaggerated 
deformation). The legend provides Von Mises stress results measured in 
N.m-2 (i.e. pascals). This was a secondary model, used to validate the 
primary model in Figure A.12. 
 
Figure A.14 FEA model of the force sensing element with negative forces applied and 
with a mesh element size of 3mm. The image indicates the Von Mises 
stress distribution results of the FEA model (with exaggerated 
deformation). The legend provides Von Mises stress results measured in 
N.m-2 (i.e. pascals). This was a secondary model, used to validate the 




Figure A.15 FEA model of a force sensing element with positive forces applied and 
with a mesh element size of 2mm. The image indicates the Von Mises 
stress distribution results of the FEA model (with exaggerated 
deformation). The legend provides Von Mises stress results measured in 
N.m-2 (i.e. pascals). This was the primary model, validated by the 
secondary models in Figure A.16 and Figure A.17. 
 
Figure A.16 FEA model of the force sensing element with positive forces applied and 
with a mesh element size of 1mm. The image indicates the Von Mises 
stress distribution results of the FEA model (with exaggerated 
deformation). The legend provides Von Mises stress results measured in 
N.m-2 (i.e. pascals). This was a secondary model, used to validate the 




Figure A.17 FEA model of the force sensing element with positive forces applied and 
with a mesh element size of 3mm. The image indicates the Von Mises 
stress distribution results of the FEA model (with exaggerated 
deformation). The legend provides Von Mises stress results measured in 
N.m-2 (i.e. pascals). This was a secondary model, used to validate the 
primary model in Figure A.15. 
 
Note that the deviation of average stresses between the primary and secondary models was minor (see 
tables A.1 and A.2), indicating that the mesh had a negligible effect on the outcomes of the model. It 
could be assumed that the results were reliable, especially considering the large safety factor.  
Also note that, as expected, the orientation of the applied force had little effect on the magnitude of 
the stresses and strain in the part. While there were differences between the outcomes of FEA model 
and those of the calculations in section A.3.1, they were probably due to simplifying assumptions 
made in each case. The FEA model was based on a geometrically accurate depiction of the final 
component, whereas the manual calculations did not take into account the effects of certain 
component design features. For example, in the manual calculations, stress concentration factors 
caused by the holes and slots were ignored. To a lesser extent, the restraint type may have been the 
cause of incongruence between the two analyses. The restraints used in the FEA model essentially 
locked the relevant design feature in space, disallowing any translation or rotation. Bending moments 




The relative agreement between the strains predicted by the FEA model and the calculations was an 
indicator that the strains predicted in the later were reliable. The strain in the gauge section as 
observed in the FEA models were approximately 100 εµ. Using Equation A.6 we can estimate that the 
corresponding output of the strain gauge circuitry would be 193 mV. In section A.3.1, an output 
voltage of 276.0 mV was predicted.  
Based on these models, the parts were fabricated as described. Once construction had been completed, 
the calibration data (Figure A.7 and Figure A.8) indicated that the force measurement circuits were 
generally more sensitive than predicted. At 30N of loading, the calibration predicted that the output 
would be up to 1.275 V depending on the sensing element and the direction of loading. This could be 
due to many factors such as uncertainty in the amplification circuitry, inaccuracy in the modelling due 
to assumptions, etc. This was not a problem, however, since the output voltage varied linearly with 
applied load and the peak voltage would not saturate the recording instrumentation.  
 
A.4.2. Finite Element Analysis of Structural Elements 
The structural components involved in the mechanical stops were also modelled with FEA (see Figure 
2.8). An approach was applied similar to that for the force sensing element (see Section A.4.1). It was 
decided to design the component conservatively and use FEA to confirm that the safety factor was 
sufficiently large.  
The structural components of interest interfaced with other structural elements at the hinges, the 
mechanical stops, the force sensing elements and the gears (see Figure A.9). The mechanical stops 
that guard against hyperextension were likely to experience the highest stress. As such, the scenario 
under which full expected load would be applied to these features was modelled: simultaneous torque 
from the motor and that due to applied force from a participant in the negative direction (i.e. 
extension). While this was an unlikely event, the device was required to be modelled under worst-case 
scenarios. 
In both the proximal and distal component models, restraints were selected to be at the hinge point 
around which the component rotated as well as the contact surface of the mechanical stop (see Figure 
A.18). Fixed hinge and sliding/roller type bearing restraints were applied at these features 
respectively. Fixed hinges allowed the inner surface of a hole to translate only tangentially, but nodes 
were restrained from moving axially or radially. Slider/roller restraints of a surface allowed 
translation of nodes parallel to the plane of the feature, but disallowed translation normal to it. As the 
names suggest, these simulated hinges and frictionless contact between two surfaces.  
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The analysis of the structural elements was performed first with the primary mesh, then with finer and 
coarser meshes for validation. Again, the primary mesh had a global element size of 2mm with site 
specific element size specified to be 1mm around the holes and along the surfaces near the mechanical 
stop. The secondary meshes had global elements of 1mm and 3mm, with site specific element sized of 
0.5mm and 1.5mm in the same locations. 
The distal and proximal structural components had different geometries and were modelled 
separately. As such, six models were created in total (see Figure A.19). The Von Mises stress 
distributions on the models‟ surfaces are shown in Figure A.20 to Figure A.25. Relevant numerical 






Figure A.18 Front views of CAD models of the proximal (top) and distal (bottom) 
structural elements that were analysed, indicating how loading and 
restraints were applied in the FEA (see Figure A.9). 
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Figure A.19 CAD models of the distal (left) and proximal (right) structural elements 
indicating the meshes used in the FEA models: 2mm mesh used as the 
primary model (centre), and the 1mm mesh (top) and 3mm mesh (bottom) 
used to confirm the results of the primary model (see Figure A.9). 
 
 
Figure A.20 FEA model of the distal structural element and with a mesh element size 
of 2mm. The image indicates the Von Mises stress distribution results of 
the FEA model (with exaggerated deformation). The legend provides Von 
Mises stress results measured in N.m-2 (i.e. pascals). This was a primary 






Figure A.21 FEA model of the distal structural element and with a mesh element size 
of 1mm. The image indicates the Von Mises stress distribution results of 
the FEA model (with exaggerated deformation). The legend provides Von 
Mises stress results measured in N.m-2 (i.e. pascals). This was a secondary 
model, used to validate the primary model in Figure A.20. 
 
 
Figure A.22 FEA model of the distal structural element and with a mesh element size 
of 3mm. The image indicates the Von Mises stress distribution results of 
the FEA model (with exaggerated deformation). The legend provides Von 
Mises stress results measured in N.m-2 (i.e. pascals). This was a secondary 






Figure A.23 FEA model of the proximal structural element and with a mesh element 
size of 2mm. The image indicates the Von Mises stress distribution results 
of the FEA model (with exaggerated deformation). The legend provides 
Von Mises stress results measured in N.m-2 (i.e. pascals). This was the 




Figure A.24 FEA model of the proximal structural element and with a mesh element 
size of 1mm. The image indicates the Von Mises stress distribution results 
of the FEA model (with exaggerated deformation). The legend provides 
Von Mises stress results measured in N.m-2 (i.e. pascals). This was a 






Figure A.25 FEA model of the proximal structural element and with a mesh element 
size of 3mm. The image indicates the Von Mises stress distribution results 
of the FEA model (with exaggerated deformation). The legend provides 
Von Mises stress results measured in N.m-2 (i.e. pascals). This was a 
secondary model, used to validate the primary model in Figure A.23. 
 
Table A.3 Relevant numerical data from the FEA model of the proximal structural 








Peak Von Mises 
stress 
[MPa] 




Secondary 1 0.5 24.18 9.65% 
Primary 2 1 22.05 - 
Secondary 3 1.5 21.08 -4.40% 
 
Table A.4 Relevant numerical data from the FEA model of the distal structural 








Peak Von Mises 
stress  
[MPa] 




Secondary 1 0.5 22.09 16.75% 
Primary 2 1 18.92 - 




It was not required of this model to know the stress at specific points. The use of sensors was not 
required. The overall safety factor of the whole part could be calculated from the peak stresses from 
the primary model for each. These were 18.92 MPa and 22.05 MPa (see Table A.3 and A.4).  
The material in question, poly(methyl methacrylate), trade name “Perspex”, has an ultimate tensile 
stress of 75 MPa, as specified by the manufacturers. The overall safety factors in the models were 3.4 
and 4.0 for the distal and proximal components respectively. Notice also that the peak stresses in the 
components occurred near the edges of restrained surfaces. These regions are susceptible to 
anomalous stress readings and the actual peak stresses were likely to be slightly lower than was 
predicted by the model. Regardless, a conservative design paradigm was confirmed by the large safety 
factors. 
It can be seen in tables A.3 and A.4 that there was some difference in peak and average stress between 
the primary models and their corresponding secondary models. Thus, the mesh had an effect on the 
outcome of the model. In light of the large safety factors, it was again decided that the model was 








Appendix B – Electronics and Actuator Information 
B.1. Electric Motor and Motor Driver Specifications 
The actuators were brushed DC electric motors (see Figure B.1). The motors specified for the device 
had the following characteristics: 
 Supply voltage: 12v 
 Unloaded rotational speed: 10 RPM 
 Rated torque: 0.59 N.m 
 Gearbox ratio: 750:1 
 
The motors were controlled by means of the L298 dual H-bridge IC, which was capable of supplying 
a total DC current of up to 4 A. The both motors were driven from a single IC.  
The H-bridge allowed bidirectional motor control without the need for a negative voltage supply. The 
IC‟s enabling pins (required to be held high at 5 volts to enable output) were hardwired to the safety 
button system so that if either safety button was released, the motors were directly disabled. As a 
redundancy, the safety button also disabled the motors in software. 
B.2. EMG Signal Acquisition 
OpenEEG circuit boards were used for acquisition of EMG (“The OpenEEG project,” 2013). The 
circuit designs were intended for use with EEG, such as with EEG-biofeedback and brain-computer 
interface applications and to facilitate research into neurophysiology. Components were replaced so 
that the bandwidth of the amplifier circuits met the requirements of EMG signal acquisition (see 
Appendix C). 
The OpenEEG system consists of separate amplifier and digital electronics (see Figure B.3 to Figure 
B.4). Each amplifier board had two signal acquisition channels. The digital boards received these 
signals and communicated them via serial connection, although this feature was not used in this study. 
Up to three amplifier boards could interface with a digital board (creating six channels), although only 
two were used since four channels were required. The digital board was only used for optical isolation 
and power management of the amplifier boards only.  
The amplifier board received its power from the digital board, which itself was required to be 
powered externally. The power supply was optically isolated from other electronics. The output of the 




Figure B.1 A geared brushed DC electric motor as used in the device. 
 
 
Figure B.2 The OpenEEG digital board (left) and amplifier board (right) (See Figure 
























































































































B.3. EMG Signal Processing Circuit 
EMG signal processing was partially performed in analogue electronics. The main functions required 
were filtering, rectifying, and enveloping (see Figure B.5 and Figure B.6). A fourth step – 
thresholding – was performed digitally by the microcontroller. 
 
Figure B.5 Functional requirements of the EMG signal processing circuit (reproduced 




Figure B.6 Schematic diagram of the EMG signal processing circuit for one channel 
(see Figure B.5). 
 
B.3.1. Filtering 
High pass filtering was performed to remove the DC offset due to the virtual ground as well as to 
reduce motion artefact. A simple RC filter was implemented, using a 2.2 μF capacitor and a 10 kOhm 





































A precision full-wave rectifier was implemented. The circuit (see Figure B.7) provided a fully 
rectified signal which was tested at frequencies up to 1000 Hz. 
 




An envelope of the rectified EMG signal was achieved was achieved by means of a peak detecting 
circuit (Horowitz and Hill, 1989). The circuit included two consecutive operational amplifier (op-
amp) sub-circuits (see Figure B.8). The first op-amp drew its negative feedback after a diode, creating 
a precision diode (without the forward voltage drop). The capacitor would hold its charge due to the 
high input impedances of the second op-amp and due to the low leakage current of the diode.  
The small input bias currents and leakage currents for the op-amps and diodes respectively resulted in 
a discharge (or “droop”) in output voltage over time. While normally seen as a circuit limitation, the 
droop was used to drop the circuit output to zero upon cessation of a muscle contraction. Through 
experimentation, it was found that a 1 µF capacitor resulted in appropriate output signal decay – i.e. 
one such that the circuit output created an envelope of the EMG input, but returned to zero promptly 




Figure B.8 Schematic of the peak detector circuit used in the EMG signal processing 
board (Horowitz and Hill, 1989). See Figure B.10. 
 
B.4. Strain Gauge Signal Processing Circuit 
Two force transducers were present in the design – once measuring the force applied at the wrist joint 
and one at the finger joint. Each had identical hardware and software configurations. 
The strain gauges were connected into a full bridge configuration to amplify bending loads (Juvinall 
and Marshek, 2011). Under expected loading each bridge produced output voltage „Vo‟ such that: 
               
(Equation B.1) 
Vex was the excitation voltage (12 V). Strain gauge manufacturers specified a gauge (GF) of 2.1, and 
the expected strain (ε) was calculated to be 142.7 µε (see Section A.3.1). As such, the maximum 
expected output was 36 mV. 
An instrumentation amplifier (INA114AP) was used to amplify the signals from the strain gauge 
bridges (see Figure B.9). The amplifier gain was selected via an external resistor RG: 
       
     
  
 
 (Equation B.2) 
RG was chosen to be 660 Ω such that the gain of the amplifier was 76.8. With the maximum bridge 
output voltage of 36 mV, the final output voltage was expected to be 276.0 mV. This was large 
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enough to be easily measured, but allowed a safety factor to prevent saturation of the data logger in 
the case of an unexpectedly large load. 
Lastly, potentiometers were used with the reference adjustment pins to adjust DC offset to “zero” the 
output (see Figure B.9).  
 
Figure B.9 Schematic of the bridge and amplifier circuit used in the strain gauge force 
measurement system (see Figure B.10). Reproduced from Figure 2.11. 
 
B.5. Microprocessor and System Integration 
A PIC16F917 microcontroller was used for system integration (see Figure B.10). Input from the 
various sub-systems was either analogue or digital. Outputs were digital control signals for the L298 
H-bridge driver to control the motors (see section B.2), as well as for indicator lights and the LCD 
display.  
Certain signals were monitored by the data logging system (see section 2.5) for the purposes of this 
study, such as raw EMG and amplified strain gauge voltage. Note that the PC only monitored signals 
from the system, and was not involved in control at all. 
The microcontroller had the following basic specifications: 
 PIC16F917, produced by Microchip Technologies 
 8-Bit CMOS Microcontrollers 
 Internal oscillator operating at 8MHz clock speed (default), programmable up to 32MHz 




Figure B.10 Functional overview of the components of the system (power management 










































Strain gauge amplifier circuit 
board1 
1 – See Section 2.4 
2 – See Section 2.3 




Aside from basic input and output (I/O), peripheral features included interrupts and analogue-to-
digital (A2D) converters. The interrupt feature was used for the limit switches to ensure rapid 
response. The eight (A2D) converters were used to monitor EMG envelope signals and activation 
thresholds as control inputs for certain modes of operation. The amplified strain gauge signals had 
dedicated A2D pins, although these were not being used in this study. 
 
B.6. User Interface Electronics 
All electronics (except the strain gauge amplifiers during the pilot clinical trial) were housed in the 
control box. The two control buttons provided a means to select modes of operation and other menu 
items. Potentiometers were used to adjust the EMG activation thresholds. Indicator lights and an LCD 
display were used to provide menu prompts and status information. 
The primary method of information display was the LCD display module. The LMB162ABC module 
was used for this application. It connected with the microcontroller via an octal buffer IC 
(74HCT541). The display consisted of a 2x16 character output, and was used to prompt the user when 










Appendix C – Modifications to the OpenEEG System 
The OpenEEG amplifiers were designed for use in electroencephalography (“The OpenEEG project,” 
2013). Modifications were made such the amplifiers were suitable for EMG acquisition. The original 
bandwidth specifications were: 
 Lower cutoff frequency: 280mHz  
 Upper cutoff frequency: 58Hz  
Useful EMG information can, however, be detected up to 500 Hz. Similarly, motion artefact 
usually occurs in the lower frequency range (<5 Hz). As such, the bandwidth of the amplifiers 
was changed to the desired range of between 5 Hz and 500 Hz.  
The cut-off frequencies of an electronic circuit can be shifted by scaling all inductors and 
capacitor such that the impedance at the original and final frequency is unchanged (Horowitz and 
Hill, 1989): 
   
 
        
 
 
        
 
X is the impedance of the filter, f is the frequency and C is the capacitance. Thus: 
    





See Table C.1 for the changes made to the OpenEEG circuits. Despite these modifications, gain of the 
amplifiers was frequency dependent. Spectral scaling was implemented to process the recorded data 
(see Appendix E). 
Table C.1 Original and replacement capacitor values for bandwidth modification of 
the OpenEEG system (see Figure B.3 and Figure B.4). 







C220 and C221 1000 56.2 57 
C228 and C229 1000 56.2 57 
Low Pass 
C321 and C235 220 25.67 22 
C232 and C233 10 1.17 1 
C234 and C236 33 3.85 3.3 








Appendix D – Calibration of the EMG Amplification System 
Four OpenEEG amplifier boards were used for amplification of EMG signals (“The OpenEEG 
project,” 2013). The output of each was an analogue signal with a peak-to-peak amplitude of 4 V (at a 
virtual ground of 2 V). These were recorded with a DAQ. It was found that the EMG amplifiers, 
modified using the method described in Appendix C, had inconsistent gains over the frequency range 
of interest (5 Hz to 500 Hz). In order to correct for frequency-dependent gains, spectral scaling was 
implemented. Transfer functions were determined empirically, and were used to determine the 
unamplified EMG amplitude using the method described in this appendix.  
Since each EMG channel had a dedicated amplifier (no multiplexing was performed), each amplifier 
was analysed separately. Signal processing was performed offline in Matlab, version R2012a.  
D.1. Generation and Amplification of the Input Signal  
In order to properly determine the transfer functions, a known signal needed to be generated and 
amplified by each channel. This unamplified input signal and the amplified output signals could be 
analysed against one another. Since EMG is of the order of microvolts to millivolts, the amplifier gain 
was expected to be large. An input signal of similarly small amplitude was required. For this purpose, 
a voltage divider was used in conjunction with a signal generator (Hewlett Packard 3314A function 
generator) to create a sine wave of sufficiently small amplitude (see Figure D.1). 
 
Figure D.1 Schematic representation of the calibration setup for a single channel. The 
input signal (from a signal generator) was attenuated with a voltage divider 
by a factor of 1001, before being amplified by the EMG amplifier. Both the 
output from the amplifier being analysed and the input to the voltage divider 










Outputs to DAQ 
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The sinusoidal input signal swept through from the minimum frequency capable with the signal 
generator through to the maximum frequency range of interest (i.e. 5 Hz to 500 Hz). The frequency 
range was chosen to be wide enough to encapsulate the majority of the EMG power. The sweep 
occurred over a time interval of roughly 14 second. The signals were recorded with a sampling 
frequency of 1000 Hz – the same as that of the actual EMG recordings made during testing - 
satisfying the Nyquist Sampling Theorem criterion; the measured signal was accurately resolved 
because the sampling rate is at least double the largest frequency of interest. 
The amplitude of the input from the signal generator was varied until the output from the amplifiers 
was 2 V peak-to-peak. This was large enough to be accurately resolved by the DAQ, but would not 
saturate the amplifiers. Subsequently, the input signal amplitude was measured and found to be 418 
mV peak-to-peak.  





(     )
 
(Equation E.1) 
Where Vo is the output voltage, Vi is the input voltage, and R1 and R2 are the two resistors used in the 
voltage divider (see Figure D.1). These were 1 KΩ and 1 MΩ respectively (with 5% accuracy). 
Accounting for resistor uncertainty, the attenuation factor could be expected to lie between 9.04 x 10-4 
and 11.04 x 10-4. When an input sine wave of amplitude 20 V peak-to-peak was applied, it yielded an 
output signal of 19 mV peak-to-peak - an attenuation factor of 9.50 x 10-4. This was in agreement with 
an estimate using Equation E.1. 
Using this attenuation factor, the input sine wave (418 mV peak-to-peak) yielded an output to the 
EMG amplifier of 0.39 mV peak-to-peak that swept through the frequency range of 5 Hz to 500 Hz. 
 
D.2. Inference of the Transfer Function 
The unattenuated input signal (from the signal generator) was multiplied by the attenuation factor 
(9.50x10-4), to yield the attenuated sinusoid which swept through the range of frequencies. The 
unattenuated signal was recorded, since the attenuated version (the output of the voltage divider) was 
too small to be recorded. Using the attenuation factor, the attenuated signal was inferred in software. 
The first second of the recording of this inferred attenuated signal is shown in Figure D.2. 
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Simultaneously, a second recording of the output of the amplifier was made. A separate output 
recording was made for each amplifier channel. An example of such a recording is shown in Figure 
D.3. The waveforms for the other channels have the same basic appearance with small variations in 
amplitude. 
Note that, in Figure D.3, the voltage spikes at 18s are due to the signal generator failing to transition 
smoothly from the 500 Hz signal to 0 V at the end of the sweep. This does not affect the calibration.    
From the data in Figure D.2 and Figure D.3, there is enough information to determine the relationship 
between frequency and amplifier gain (i.e. transfer function). As can be seen from Figure D.3, the 
gain of the amplifier is dependent on the frequency of the input. This points to an error, either in the 
calculations for the modifications to the OpenEEG boards (see Appendix C), or the implementation 
thereof. Regardless, the transfer functions could be used to infer the unamplified EMG signals. 
 
In Matlab, using the „tfestimate‟ function, the transfer function, and also the phase shift 
characteristics, of the amplifier can be estimated based on the input and output vectors (such as those 
shown in Figure D.2 and Figure D.3). This process was repeated for all amplifier channels, and the 
gains and phase shifts for each are shown in Figure D.4. In Matlab, the gains over the frequency range 
were stored in a vector, referred to as the transfer function vector. The measured bandwidths of the 
amplifiers (i.e. the range in which the gain is within 3.01 dB of the peak) are shown in Table E.1. 















1 23.7 5.6 100.8 6.66 
2 19.3 5.6 100.8 6.50 
3 19.3 6.1 100.5 5.35 






Figure D.2 The first second of the recording of the attenuated input signal to the 
amplifier for calibration. The initial frequency was 5 Hz (shown at time 0 
seconds here), and over roughly 14 seconds it swept through to 500 Hz. 
Using this data, and that shown in Figure D.3, the amplifier characteristics 
could be determined (see Figure D.4) 
 
 
Figure D.3 The recording of the amplified output signal from the amplifier for 
calibration. The input signal is shown in Figure D.2. The initial frequency 
was 5 Hz and over 15 seconds it swept through to 500 Hz. Using this data, 
and that shown in Figure D.2, the amplifier characteristics could be 






As can be seen from Table E.1, the bandwidths of the amplifiers are very narrow. The upper cutoff 
frequencies are roughly 100 Hz, and the lower cutoff frequencies were recorded as roughly 5 Hz. 
Note that the latter could be due to the fact that the function generator signal sweep only began at 5 
Hz. Regardless, signals below this range are not of interest, as they are likely to be affected by 
disturbances such as baseline drift due to movement of the participant. 
Despite the narrow bandwidth, inference of the unamplified EMG data from the recordings is still 
possible.  The majority of EMG power lies below 150 Hz (see the Fourier transforms of the recorded 
signals in Figure D.6). Amplification is sufficient, however, that computation of unamplified data up 
to 500 Hz is still possible. The decibel drop at 150 Hz is show in Table E.1. 
 
D.3. Inference of Unamplified EMG signals 
To allow for comparison of EMG across participants, the unamplified EMG data must be inferred 
from the raw, amplified data that was recorded. This section illustrates the method used to infer the 
unamplified EMG by means of an example. 
The following method was used to correct the recorded EMG signals: 
 Since the transfer functions were dependent of frequency, the recorded EMG needed to be 
analysed in the frequency domain. A discrete Fourier transform was applied to determine the 
EMG spectral density. 
 Once the vector containing the spectral density distribution of the EMG recording had been 
established, it was divided by the amplifier gain vector (also in the frequency domain). In this 
way, the components of the EMG across the frequency spectrum would be corrected using the 
appropriate gain for that frequency.  
 The corrected EMG spectral density was then converted back into the time domain to yield 
the corrected EMG. 
 
A discrete Fourier transform was used to determine the spectral density of the recorded EMG data. 








Figure D.4 Estimates of the transfer functions (top) and phase shifts (bottom) for each 
amplifier channel. Amplifier characteristics are based on the input and 
output recordings such as those shown in Figure D.2 and Figure D.3. The 
estimates were made using the “tfestimate” function in Matlab. Notice that 
the functions are not constant over the frequency. The disruptions observed 





Figure D.5 Example of an amplified EMG waveform. Data was collected from the 
flexor carpi radialis muscle, amplified and recorded using channel 4. (See 
Figure D.4 for amplifier characteristics).  
 
The spectral density vector was divided by the transfer function vector (see Figure D.4), such that the 
amplitude of the EMG was corrected on the basis of its frequency components (see Figure D.6). 
Once the corrected spectral density had been obtained, the inverse Fourier transform could be invoked 
to determine the unamplified EMG signal in the time domain. To implement this, the „ifft‟ function in 





Figure D.6 Top: The spectral density of the EMG recording shown in Figure D.5. 
Middle: The transfer function for channel 4 (see Figure D.4). Bottom: The 
final, unamplified spectral density, inferred by dividing the EMG spectral 
density vector by the transfer function vector (see Figure D.7) for the 





Figure D.7 Original (amplified) and final (unamplified) EMG data, as inferred from the 












Appendix E – Microcontroller Code 
The following code was used in the microcontroller (PIC16F917) to integrate the various sub-
systems. These were namely: 
 Four analogue input to capture the processed EMG envelope 
 Two analogue input to capture the EMG threshold adjustments (these also served the dual 
purpose of allowing manual control of the device if position adjustments needed to be made) 
 Functionality for the four limit switches on the device 
 Pushbuttons on the control box 
 The LCD display module 
 The safety buttons (using an interrupt algorithm) 
 Bidirectional control of each motor 
The code was developed in MPLab v8.50 Development Environment, and required the use of the 
HITECH C compiler plug-in. The compiled algorithm was uploaded to the microcontroller using a 
PICkit 2 uploader, distributed by Microchip Technology Inc.  The code was as follows. 
/*This version includes functionality for: 
two modes of operation: EMG driven and evaluation mode. The following is functional in the code below: 
 4x EMG channel input (with "hysteresis thresholds" and further smoothing) 
 2x manual control using threshold pots 
 Threshold adjustment input (analog x2) 
 Limit switchs (x4) 
 Safety buttons (with interrupt, x1) 




#include "LCD library.C" 
 
//variables and arrays: 
unsigned int SAFE=0;     //status of safety buttons 
unsigned int FLAG[4];     //for thresholding 
float EMG_IN[4];      //read in EMG 
float EMG_MA[4];      //EMG after smoothing 
float THRESHOLD[2];      //read in from pots 





int run_time=30000;   //used to move motors to neutral position during intiialization. Value depends on 
motor type - set higher if slower motors 
 
//index variables: 
unsigned int i=0; 
unsigned int j=0; 





void interrupt isr();       //immediately kill motors and change SAFE 
to false if push buttons released 
short analog_read_in (int channel);    //read in analog signals (EMG, thresholds, strain 
gauges) 
int bool_EMG(float EMG, float THRESH, int FLAG);//change analog EMG signal into binary value depending on threshold 
values  

















void main (void) 
{ 
//setup and initialize: 
TRISA=0b11111111;      //PORTA (EMG, strain gauge, threshold 
inputs) as input 
TRISB=0b11111111;      //PORTB (limit switches) as input 
TRISE=0b11111111;      //PORTE (EMG, strain gauge, threshold 
inputs) as input 
TRISC=0;       //PORTC (motor control) as output 





CMCON0=0;       //turn off comparators 
ANSEL=0b11111111;      //RA0,RA1,RA2,... = analog input (all AN 
inputs set to analog) 
ADCON1=0b01100000;      //Timing for analog input  
SSPCON=0; 
T1CON=0; 
RCSTA=0;       //disable serial port (free up RC6 and RC7) 
LCDCON=0;       //disable PIC LCD driver module 
 
lcd_init();       //initialize LCD module - function in include 
file "LCD library.C" 
 
//interrupt config: 
//RBPU=0;       //disable weak pullups on PortB 
INTCON=0b10010000;      //enable external interrupts only. 
INTEDG=0;       //killswitches (RB0) set to falling edge - 
trigger killswitch if buttons are released 
 
//display welcome screen 
lcd_string("Welcome");      //display text 
 
for (i=0;i<60000;i++);      //wait 
 
lcd_command(0x01);      //clear screen 
lcd_string("A: EMG mode");      //display text 
lcd_command(0xc0);      //next line 







 //Confirmation of mode selection: 
 {lcd_command(0x01);     //clear screen 
 lcd_string("EMG mode?");     //display text 
 for (i=0;i<60000;i++);     //short pause 
 lcd_command(0xc0);     //next line 
 lcd_string("A: Confirm");     //display text 
 while(!RB2);      //wait and poll pushbutton 1 
 //envoke EMG control 
 EMG_control(); 
 } 
if (RB3)         
 //Confirmation of mode selection: 
 {lcd_command(0x01);     //clear screen 
 lcd_string("Eval mode?");     //display text 
 for (i=0;i<60000;i++);     //short pause 
 lcd_command(0xc0);     //next line 
 lcd_string("A: Confirm");     //display text 
 while(!RB2);      //wait and poll pushbutton 1 
 
 //choose eval mode (wrist or wrist + fingers) 
 {lcd_command(0x01);     //clear screen 
 lcd_string("Which Eval mode?");    //display text 
 for (i=0;i<60000;i++);     //short pause 
 lcd_command(0xc0);     //next line 
 lcd_string("A: W+F  B: W");     //display text 
 while(1) 
  {if(RB2)      //wait and poll pushbutton 1 
  //envoke Eval control 
   Eval_control(); 
  if(RB3)      //wait and poll pushbutton 2 
  //envoke EvalW control 
   EvalW_control(); 













void interrupt isr()     
{ for (i=0;i<100;i++)      //when the external interrupt pin is 
deactivated 
 if (!RB0)         
  { 
  SAFE=0;      //change SAFE to false to disable future 
activations of motors until safety button is held again  
  RC0=0;      //and deactivate all motors before returning 
to calling function 
  RC1=0; 
  RC2=0; 
  RC3=0; 












 case 0: 
  ADCON0=0b10000001;    //AN0 - Strain gauge input channel 1 (not in 
use yet) 
  break; 
 case 1: 
  ADCON0=0b10000101;    //AN1 - Strain gauge input channel 2 (not in 
use yet) 
  break; 
 case 2: 
  ADCON0=0b10001001;    //AN2 - EMG channel 1 
  break; 
 case 3: 
  ADCON0=0b10001101;    //AN3 - EMG channel 2 
  break; 
 case 4: 
  ADCON0=0b10010001;    //AN4 - EMG channel 3 
  break; 
 case 5: 
  ADCON0=0b10010101;    //AN5 - EMG channel 4 
  break; 
 case 6: 
  ADCON0=0b10011001;    //AN6 - threshold 1 
  break; 
 case 7: 
  ADCON0=0b10011101;    //AN7 - threshold 2 
  break; 
 default: 
  break; 
 } 
for (j=0;j<10;j++);       //wait to charge capacitor 
unsigned int ADCON_old=ADCON0+2;    //save value of ADCON0 for later 
comparison to determine flag bit status 
ADCON0=ADCON0+2;      //begin conversion (set second bit of 
ADCON0 high) 
while (ADCON0==ADCON_old);     //wait for conversion (flag bit will 
automatically go low when complete) 
ADCON0=0;       //reset ADCON0 (not strictly necessary) 




====int bool_EMG(float EMG, float THRESH, int FLAG) 
{ 
if (EMG>THRESH)      //if EMG obove threshold, 
 { 
 FLAG=1;      //FLAG used to determine hysteresis 
between thresholds 
 return 1;       //if High threshold > EMG > low threshold, 
then function will return 1 if FLAG== 1 and 0 if FLAG==0.  
 } 
else 
 if (EMG>(0.1*THRESH))     //low threshold is 30% of high threshold 
  { 
  if (FLAG==1) 
   return 1; 
  else 
   return 0; 
  } 
 else 
  { 
  FLAG=0; 
  return 0; 












 while (RB3)      //loop as long as manual button is pressed 
  { 
  THRESHOLD[0] = analog_read_in(6); //read-in of threshold values 
  THRESHOLD[1] = analog_read_in(7); 
 
 if (THRESHOLD[1]>200 && THRESHOLD[1]<800 && THRESHOLD[0]>200 && THRESHOLD[0]<800)
         //wait till both thresholds are in 
inactive range 
   break;     //continue to rest of function 
  else 
   {     //kill motors and continue to wait 
   RC0=0; 
   RC1=0; 
   RC2=0; 
   RC3=0;  
   } 
  } 
 while (RB3) 
  { 
  THRESHOLD[0] = analog_read_in(6); //read-in of threshold values for motor control 
  THRESHOLD[1] = analog_read_in(7); 
  
//Same actions as for EMG mode, but with different conditions for activation. 
  if (!RB0)      //if killswith released, change SAFE to false 
and kill motors 
   {     //Note: this action is repeated in the interrupt 
isr() function for redundency 
   RC0=0; 
   RC1=0; 
   RC2=0; 
   RC3=0; 
   SAFE=0; 
   } 
  else      //else set SAFE to true 
   {SAFE=1;     
   } 
  
  //Motor 1 - finger 
  if (THRESHOLD[1]>200 && THRESHOLD[1]<800) 
   { 
   RC2=0;     //kill motor 
   RC3=0; 
   } 
  if (THRESHOLD[1]>800 && SAFE)      
   {if (RB4)     //finger flexion limit switch 
    {RC2=0;    //flex fingers 
     RC3=1;        //flex fingers 
    } 
   else 
    {RC3=0; 
    RC2=0; 
    } 
   } 
  if (THRESHOLD[1]<200 && SAFE) 
   {if (RB5)     //finger extention limit switch 
    {RC3=0;    //extend fingers 
     RC2=1;        //extend fingers 
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    } 
   else 
    {RC3=0; 
    RC2=0; 
    } 
   } 
  //Motor 2 - wrist 
  if (THRESHOLD[0]>200 && THRESHOLD[0]<800) 
   { 
   RC1=0;     //kill motor if no EMG activity 
   RC0=0; 
   } 
  if (THRESHOLD[0]>800 && SAFE)      
   
   {if (RB6)     //wrist flexion limit switch 
    {RC1=0;    //flex wrist 
     RC0=1;        //flex wrist 
    } 
   else 
    {RC0=0;  
    RC1=0; 
    } 
   } 
  if (THRESHOLD[0]<200 && SAFE) 
   {if (RB7)     //wrist extention limit switch 
    {RC0=0;    //extend wrist 
     RC1=1;        //extend wrist 
    } 
   else 
    {RC0=0; 
    RC1=0; 
    } 
   } 









lcd_command(0x01);      //clear screen 
lcd_string("EMG mode. Hold");     //display text 
lcd_command(0xc0);      //next line 
lcd_string("'B' for manual");      //display text 
while (1) 
{ 
 if (RB3) 
  manual_control(); 
 RD0=0;       //change LEDs to show normal mode is 
active 
 RD1=1; 
 //reading in of EMG: 
 EMG_IN[0]=analog_read_in(2);       
 EMG_IN[1]=analog_read_in(3); 
 EMG_IN[2]=analog_read_in(4);       
 EMG_IN[3]=analog_read_in(5);       
  






 //reading in of threshold: 
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 THRESHOLD[0] = analog_read_in(6); 
 THRESHOLD[1] = analog_read_in(7); 
 THRESHOLD[0] = THRESHOLD[0]*0.3;   //decrease sensitivity of threshold pots 
 THRESHOLD[1] = THRESHOLD[1]*0.3;   
 
 //Schmidt trigger: 
 EMG_BINARY[0]=bool_EMG(EMG_MA[0],THRESHOLD[1],FLAG[0]); //finger flexor muscles 
 EMG_BINARY[1]=bool_EMG(EMG_MA[1],THRESHOLD[1],FLAG[1]); //finger extensor muscles 
 EMG_BINARY[2]=bool_EMG(EMG_MA[2],THRESHOLD[0],FLAG[2]); //wrist flexor muscles 
 EMG_BINARY[3]=bool_EMG(EMG_MA[3],THRESHOLD[0],FLAG[3]); //wrist extensor muscles 
 
//  Action: 
//**************************************************** 
// the pins RC<0:3> control the motor direction. RC0 and RC1 should not be high together, neither should RC2 and 
RC3.  
// Each pin has the following function: 
// RC0 - wrist motor flexion 
// RC1 - Wrist motor extension 
// RC2 - finger motor extension 
// RC3 - finger motor flexion. 
//  
// The following is the convention for the limit switches (High is unengaged): 
// !RB4 - finger flexion limit switch - !RB4 
// !RB5 - finger extention limit switch - !RB5 
// !RB6 - wrist flexion limit switch - !RB6 
// !RB7 - wrist extention limit switch - !RB7 
//**************************************************** 
 
 checksafe();      //check safety button 
 
 if (!EMG_BINARY[0] && !EMG_BINARY[1]) 
  { 
  RC2=0;      //kill motor if no EMG activity 
  RC3=0; 
  } 
 if (EMG_BINARY[0] && EMG_BINARY[1]) 
  { 
  RC2=0;      //kill motor if dual antagonistic EMG 
activity 
  RC3=0; 
  } 
 
 if (EMG_BINARY[0] && !EMG_BINARY[1] && SAFE)      
  {if (RB4)      //finger flexion limit switch 
   {RC2=0;     //flex fingers 
    RC3=1;         //flex fingers 
   } 
  else 
   {RC3=0; 
   RC2=0; 
   } 
  } 
 if (!EMG_BINARY[0] && EMG_BINARY[1] && SAFE) 
  {if (RB5)      //finger extention limit switch 
   {RC3=0;     //extend fingers 
    RC2=1;         //extend fingers 
   } 
  else 
   {RC3=0; 
   RC2=0; 
   } 
  } 
 
 if (!EMG_BINARY[2] && !EMG_BINARY[3]) 
  { 
  RC1=0;      //kill motor if no EMG activity 
154 
 
  RC0=0; 
  } 
 if (EMG_BINARY[2] && EMG_BINARY[3]) 
  { 
  RC1=0;      //kill motor if dual antagonistic EMG 
activity 
  RC0=0; 
  } 
 if (EMG_BINARY[2] && !EMG_BINARY[3] && SAFE)   
  {if (RB6 && !RC2)    //wrist flexion limit switch and check to 
disable when fingers are extending 
   {RC1=0;     //flex wrist 
    RC0=1;         //flex wrist 
   } 
  else 
   {RC0=0;  
   RC1=0; 
   } 
  } 
 if (!EMG_BINARY[2] && EMG_BINARY[3] && SAFE) 
  {if (RB7 && !RC3)    //wrist extention limit switch and check to 
disable when fingers are flexing 
   {RC0=0;     //extend wrist 
    RC1=1;         //extend wrist  
   } 
  else 
   {RC0=0; 
   RC1=0; 
   } 







lcd_command(0x01);      //clear screen 
lcd_string("Eval mode.");      //display text 
lcd_command(0xc0);      //next line 
lcd_string("Initializing...");      //display text 
for (i=0;i<60000;i++);      //short pause 
if (!RB0) 
{ 
 lcd_command(0x01);     //clear screen 
 lcd_string("Please hold");     //display text 
 lcd_command(0xc0);     //next line 
 lcd_string("safety button.");     //display text 
 while(!RB0);      //wait for safety buttons   
 lcd_command(0x01);     //clear screen 
 lcd_string("Eval mode.");     //display text 
 lcd_command(0xc0);     //next line 




EFM();        //Extend fingers to max, short pause 
EWM();        //Extend wrist to max, short pause 
FWS();        //flex wrist to straight, short pause 
FF45();        //flex fingers to 45' 
 
lcd_command(0x01);      //clear screen 
lcd_string("Please secure");      //display text 
lcd_command(0xc0);      //next line 






lcd_command(0x01);      //clear screen 
lcd_string("Press 'A' when");      //display text 
lcd_command(0xc0);      //next line 
lcd_string("ready");      //display text 
 




lcd_command(0x01);      //clear screen 
lcd_string("Repeat?");      //display text 
lcd_command(0xc0);      //next line 
lcd_string("A: Yes, B: No");      //display text 
 







lcd_command(0x01);      //clear screen 
lcd_string("Test complete");      //display text 
lcd_command(0xc0);      //next line 








lcd_command(0x01);      //clear screen 
lcd_string("Eval(W) mode.");     //display text 
lcd_command(0xc0);      //next line 
lcd_string("Initializing...");      //display text 
for (i=0;i<60000;i++);      //short pause 
if (!RB0) 
{ 
 lcd_command(0x01);     //clear screen 
 lcd_string("Please hold");     //display text 
 lcd_command(0xc0);     //next line 
 lcd_string("safety button.");     //display text 
 while(!RB0);      //wait for safety buttons   
 lcd_command(0x01);     //clear screen 
 lcd_string("Eval mode.");     //display text 
 lcd_command(0xc0);     //next line 




EFM();        //Extend fingers to max, short pause 
EWM();        //Extend wrist to max, short pause 
FWS();        //flex wrist to straight, short pause 
FF45();        //flex fingers to 45' 
 
lcd_command(0x01);      //clear screen 
lcd_string("Please secure");      //display text 
lcd_command(0xc0);      //next line 




lcd_command(0x01);      //clear screen 
lcd_string("Press 'A' when");      //display text 
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lcd_command(0xc0);      //next line 
lcd_string("ready");      //display text 
 




lcd_command(0x01);      //clear screen 
lcd_string("Repeat?");       //display text 
lcd_command(0xc0);      //next line 
lcd_string("A: Yes, B: No");      //display text 
 







lcd_command(0x01);      //clear screen 
lcd_string("Test complete");      //display text 
lcd_command(0xc0);      //next line 









if (!RB0)        //if killswith released, change SAFE to false 
and kill motors 
  {      //Note: this action is repeated in the interrupt 
isr() function for redundency 
  RC0=0; 
  RC1=0; 
  RC2=0; 
  RC3=0; 
  SAFE=0; 
  } 
 else       //else set SAFE to true 
  {SAFE=1;     







lcd_command(0x01);      //clear screen 
for (i=0;i<60000;i++); 
lcd_string("Test in");      //display text 
lcd_command(0xc0);      //next line 
lcd_string("progress");      //display text 
 




EFM(); //extend fingers to max then pause for 60000 cycles 
for (i=0;i<60000;i++);  //long pause 
for (i=0;i<60000;i++);  //long pause 
for (i=0;i<60000;i++);  //long pause 
FFM(); //flex fingers to max then pause for 60000 cycles. 
EFM(); //extend fingers to max then pause for 60000 cycles 
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FF45(); //flex fingers to roughly 45 degrees then pause for 60000 cycles 
FWM(); //flex wrist to max then pause for 60000 cycles 
EWM(); //extend wrist to max then pause for 6000 cycles 
FWS(); //flex wrist to straight then pause for 60000 cycles 





void EvalW_rep(void)   
{ 
lcd_command(0x01);      //clear screen 
for (i=0;i<60000;i++); 
lcd_string("Test in");      //display text 
lcd_command(0xc0);      //next line 
lcd_string("progress");      //display text 
 




EWM(); //extend wrist to max then pause for 6000 cycles 
FWM(); //flex wrist to max then pause for 60000 cycles 
EWM(); //extend wrist to max then pause for 6000 cycles 





//  Action: 
//**************************************************** 
// the pins RC<0:3> control the motor direction. RC0 and RC1 should not be high together, neither should RC2 and 
RC3.  
// Each pin has the following function: 
// RC0 - wrist motor flexion 
// RC1 - Wrist motor extension 
// RC2 - finger motor extension 
// RC3 - finger motor flexion. 
//  
// The following is the convention for the limit switches (High is unengaged): 
// !RB4 - finger flexion limit switch 
// !RB5 - finger extention limit switch 
// !RB6 - wrist flexion limit switch 











 if (!RB4)       //flex fingers to max, wait at limit for 60000 
cycles 
  { 
  RC2=0; 
  RC3=0; 
  i++; 
  } 
 else 
 { 
 checksafe();      //check safe to move 
 if (SAFE && RB4) 
  { 
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  RC2=0; 
  RC3=1;      //flex fingers 
  if (speed<speed_max) 
   {speed++; 
   for (j=0; j<speed; j++);   //soft start using PWM 
   RC3=0; 
   for (j=0; j<(speed_max-speed); j++); 
   } 
  }  
 else 
  { 
  RC3=0; 
  RC2=0; 











 if (!RB5)       //extend fingers to max, wait at limit for 
60000 cycles 
  { 
  RC2=0; 
  RC3=0; 
  i++; 
  } 
 else 
 { 
 checksafe();      //check safe to move 
 if (SAFE && RB5) 
  { 
  RC3=0; 
  RC2=1;      //flex fingers 
  if (speed<speed_max) 
   {speed++; 
   for (j=0; j<speed; j++);   //soft start using PWM 
   RC2=0; 
   for (j=0; j<(speed_max-speed); j++); 
   } 
  }  
 else 
  { 
  RC2=0; 
  RC3=0; 











 if (!RB6)       //extend wrist to max, wait at limit for 60000 
cycles 
  { 
  RC1=0; 
  RC0=0; 
  i++; 
159 
 
  } 
 else 
 { 
 checksafe();      //check safe to move 
 if (SAFE && RB6) 
  { 
  RC1=0; 
  RC0=1;      //flex fingers 
  if (speed<speed_max) 
   {speed++; 
   for (j=0; j<speed; j++);   //soft start using PWM 
   RC0=0; 
   for (j=0; j<(speed_max-speed); j++); 
   } 
  }  
 else 
  { 
  RC0=0; 
  RC1=0; 












 if (!RB7)       //extend wrist to max, wait at limit for 60000 
cycles 
  { 
  RC0=0; 
  RC1=0; 
  i++; 
  } 
 else 
 { 
 checksafe();      //check safe to move 
 if (SAFE && RB7) 
  { 
  RC0=0; 
  RC1=1;      //flex fingers 
  if (speed<speed_max) 
   {speed++; 
   for (j=0; j<speed; j++);   //soft start using PWM 
   RC1=0; 
   for (j=0; j<(speed_max-speed); j++); 
   } 
  }  
 else 
  { 
  RC0=0; 
  RC1=0; 











for (i=0;i<run_time;)      //flex fingers to roughly 45 degrees - Adjust 
terminating value for i in "for" loop till correct 
{checksafe(); 
if (SAFE && RB6) 
 { 
 RC1=0; 
 RC0=1;       //flex fingers 
 if (speed<speed_max) 
  {speed++; 
  for (j=0; j<speed; j++);    //soft start using PWM 
  RC0=0; 
  for (j=0; j<(speed_max-speed); j++); 
  } 
 i++; 














====void FF45(void)       //Flex fingers to 45 degrees 
{speed=speed_min; 
for (i=0;i<run_time;)      //flex fingers to roughly 45 degrees - Adjust 
terminating value for i in "for" loop till correct 
{checksafe(); 
if (SAFE && RB4) 
 { 
 RC2=0; 
 RC3=1;       //flex fingers 
 if (speed<speed_max) 
  {speed++; 
  for (j=0; j<speed; j++);    //soft start using PWM 
  RC3=0; 
  for (j=0; j<(speed_max-speed); j++); 
  } 
 i++; 


















Appendix F – Matlab Code 
The following section contains the Matlab code used to process the raw force data collected during 
the pilot clinical trial (see Section 3.2). The code was executed, and the resulting data plots are 
presented in Section 4.2. The code was developed in Matlab version R2012a. The code was as 
follows: 
%This program reads in data from text files and processes it in the 
following ways: 
% - Filterring to remove electrical noise from motors 
% - Removes baseline drift 
% - EMG 50Hz notch filter (electrical noise) 
  
%List of variables and their purposes: 
%RAW - raw data, read in directly from file 





%READ IN DATA: 
%============ 
%read in baseline drift values (BLDRIFT and NOISE vectors)  
%UPDATE FOR TYPE OF TEST PERFORMED (Wrist + fingers or Wrist only) 
DRIFT=dlmread('Hand out W+F.txt'); 
S_noise=size(DRIFT); 
  
%read in participant data  






BASELINE=mean(RAW(1:1000,2));   %average of first second of reading. 
RAW(:,2)= RAW(:,2)-BASELINE;    %Zero data 
BASELINE_drift=mean(DRIFT(1:1000,2)); 
  
%DETERMINE TIME MARKERS: 
%======================= 




    if(DRIFT(i,2)-BASELINE_drift<-0.3 && i>ilim) 
        MARKERS_drift(j)=i; 
        ilim=i+1000; 
        j=j+1; 
    end 
end 
  
%determine data markers 
Fc=200; 













    if(DATA_noise(i,2)<-0.15 && i>ilim) 
        MARKERS_data(j)=i; 
        ilim=i+1000; 
        j=j+1; 
    end 
end 
  
%CROP DATA FOR TIME WINDOW: 
%========================== 
%start/end at same time 
START_TIME_data=MARKERS_data(1)-2000; %identify start and end times 
END_TIME_data=MARKERS_data(numel(MARKERS_data))+2000; 
  
START_TIME_noise=MARKERS_drift(1)-2000; %identify start and end times 
END_TIME_noise=MARKERS_drift(numel(MARKERS_drift))+2000; 
  
DATA=zeros(END_TIME_data-START_TIME_data,2); %create matrix of approtriate 
time window 
for i=START_TIME_data:END_TIME_data 
    DATA(i+1-START_TIME_data,1)=i-START_TIME_data; 
    DATA(i+1-START_TIME_data,2)=RAW(i,2); 
end 
  
DRIFT_adjusted=zeros(END_TIME_noise,2); %create matrix of approtriate time 
window 
for i=START_TIME_noise:END_TIME_noise 
    DRIFT_adjusted(i+1-START_TIME_noise,1)=i-START_TIME_noise; 








%SEGMENT, RESIZE AND CONCATENATE DRIFT DATA 
%================================================ 
%segment drift data 
pause_big = 781; 










































































    if (round(i/ratio2)>0.5) 
        SEG_2_DRIFT_RESIZED(i)=SEGMENT_2_DRIFT(round(i/ratio2)); 
    else 
        SEG_2_DRIFT_RESIZED(i)=SEGMENT_2_DRIFT(round(i/ratio2+1)); 
    end 
end 
for i=1:Sseg3_data 
    if (round(i/ratio3)>0.5) 
        SEG_3_DRIFT_RESIZED(i)=SEGMENT_3_DRIFT(round(i/ratio3)); 
    else 
        SEG_3_DRIFT_RESIZED(i)=SEGMENT_3_DRIFT(round(i/ratio3+1)); 
    end 
end 
for i=1:Sseg4_data 
    if (round(i/ratio4)>0.5) 
        SEG_4_DRIFT_RESIZED(i)=SEGMENT_4_DRIFT(round(i/ratio4)); 
    else 
        SEG_4_DRIFT_RESIZED(i)=SEGMENT_4_DRIFT(round(i/ratio4+1)); 
    end 
end 
for i=1:Sseg5_data 
    if (round(i/ratio5)>0.5) 
        SEG_5_DRIFT_RESIZED(i)=SEGMENT_5_DRIFT(round(i/ratio5)); 
    else 
        SEG_5_DRIFT_RESIZED(i)=SEGMENT_5_DRIFT(round(i/ratio5+1)); 
    end 
end 
for i=1:Sseg6_data 
    if (round(i/ratio6)>0.5) 
        SEG_6_DRIFT_RESIZED(i)=SEGMENT_6_DRIFT(round(i/ratio6)); 
    else 
        SEG_6_DRIFT_RESIZED(i)=SEGMENT_6_DRIFT(round(i/ratio6+1)); 
    end 
end 
for i=1:Sseg7_data 
    if (round(i/ratio7)>0.5) 
        SEG_7_DRIFT_RESIZED(i)=SEGMENT_7_DRIFT(round(i/ratio7)); 
    else 
        SEG_7_DRIFT_RESIZED(i)=SEGMENT_7_DRIFT(round(i/ratio7+1)); 
    end 
end 
%concatenate drift segments 
RESIZED(:,2)=[SEGMENT_1_DRIFT; SEG_2_DRIFT_RESIZED'; PAUSE1drift ; 
SEG_3_DRIFT_RESIZED'; PAUSE2drift ; SEG_4_DRIFT_RESIZED'; PAUSE3drift ; 
SEG_5_DRIFT_RESIZED'; PAUSE4drift ; SEG_6_DRIFT_RESIZED'; PAUSE5drift ; 





%smooth drift segments 
Fc=50; 





%SUBTRACT DRIFT FROM TEST DATA: 
%============================== 
%subtract drift from data and smooth 
if S_resized_drift(1,1) < END_TIME_data-START_TIME_data 
    S_final=S_resized_drift(1,1); 
else 





    CORRECTED(i,1)=i; 











[b,a] = butter(1,Fc/500); 
CORRECTED_s_HP(:,2)=CORRECTED_s(:,2)-filter(b,a,CORRECTED_s(:,2))+0.5; 
  
%IDENTIFY PEAK STRESS IN EXTENSION PHASE 
%======================================= 
%Marker identifying beginning of extension phase: 
MARKER_start = 5; 
T_start = MARKERS_data(MARKER_start); 
T_end = MARKERS_data(MARKER_start+1); 
  
PEAK_volts = min(CORRECTED_s(T_start:T_end,2)); 
if PEAK_volts < 0 
    PEAK_force = PEAK_volts/-0.0425 
else 
    PEAK_force = PEAK_volts/-0.0216 
end 
  





file = fopen('Awrist.txt','w+'); 
for i= 1:length(CORRECTED_s) 




%convert force data to newtons: 
%============================== 
for i=1:length(CORRECTED_s) 
    if CORRECTED_s(i,2)<0 
        CORRECTED_s(i,2)=CORRECTED_s(i,2)/-0.0425; 
    else 
        CORRECTED_s(i,2)=CORRECTED_s(i,2)/-0.0216; 
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hFig = figure(1); 
























Appendix G – Facility Approval Documentation and Participant 
Consent Forms 
